1
|
Scott J, Iorfino F, Capon W, Crouse J, Nelson B, Chanen AM, Dwyer D, Conus P, Bechdolf A, Ratheesh A, Raballo A, Yung A, Berk M, McKenna S, Hockey S, Hutcheon A, Scott E, McGorry P, Shah J, Hickie IB. Staging 2.0: refining transdiagnostic clinical staging frameworks to enhance reliability and utility for youth mental health. Lancet Psychiatry 2024; 11:461-471. [PMID: 38643773 DOI: 10.1016/s2215-0366(24)00060-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/01/2023] [Revised: 02/11/2024] [Accepted: 02/16/2024] [Indexed: 04/23/2024]
Abstract
Globally, 75% of depressive, bipolar, and psychotic disorders emerge by age 25 years. However, these disorders are often preceded by non-specific symptoms or attenuated clinical syndromes. Difficulties in determining optimal treatment interventions for these emerging mental disorders, and uncertainties about accounting for co-occurring psychopathology and illness trajectories, have led many youth mental health services to adopt transdiagnostic clinical staging frameworks. In this Health Policy paper, an international working group highlights ongoing challenges in applying transdiagnostic staging frameworks in clinical research and practice, and proposes refinements to the transdiagnostic model to enhance its reliability, consistent recording, and clinical utility. We introduce the concept of within-stage heterogeneity and describe the advantages of defining stage in terms of clinical psychopathology and stage modifiers. Using examples from medicine, we discuss the utility of categorising stage modifiers into factors associated with progression (ie, potential predictors of stage transition) and extension (ie, factors associated with the current presentation that add complexity to treatment selection). Lastly, we suggest how it is possible to revise the currently used transdiagnostic staging approach to incorporate these key concepts, and how the revised framework could be applied in clinical and research practice.
Collapse
Affiliation(s)
- Jan Scott
- Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK; Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.
| | - Frank Iorfino
- Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia
| | - William Capon
- Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia
| | - Jacob Crouse
- Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia
| | - Barnaby Nelson
- Orygen and Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia
| | - Andrew M Chanen
- Orygen and Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia
| | - Dominic Dwyer
- Orygen and Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia
| | - Philippe Conus
- General Psychiatry Service, Lausanne University Hospital, Lausanne, Switzerland
| | - Andreas Bechdolf
- Department of Psychiatry and Psychotherapy, CCM, Charité Universitatsmedizin, Berlin, Germany
| | - Aswin Ratheesh
- Orygen and Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia
| | - Andrea Raballo
- Faculty of Biomedical Sciences, Universita della Svizzera Italiana, Lugano, Switzerland
| | - Alison Yung
- Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University and Barwon Health, Geelong, VIC, Australia
| | - Michael Berk
- Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University and Barwon Health, Geelong, VIC, Australia
| | - Sarah McKenna
- Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia
| | - Samuel Hockey
- Lived Experience Working Group, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia
| | - Alexis Hutcheon
- Lived Experience Working Group, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia
| | - Elizabeth Scott
- Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia
| | - Pat McGorry
- Orygen and Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia
| | - Jai Shah
- Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Ian B Hickie
- Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia
| |
Collapse
|
2
|
Lee TY, Lee H, Lee J, Lee Y, Rhee SJ, Park DY, Paek MJ, Kim EY, Kim E, Roh S, Jung HY, Kim M, Kim SH, Ahn YM, Ha K, Kwon JS. The characteristics and clinical outcomes of a pluripotent high-risk group with the potential to develop a diverse range of psychiatric disorders. J Psychiatr Res 2024; 174:237-244. [PMID: 38653032 DOI: 10.1016/j.jpsychires.2024.04.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/25/2023] [Revised: 03/26/2024] [Accepted: 04/03/2024] [Indexed: 04/25/2024]
Abstract
BACKGROUND Recent studies have indicated that clinical high risk for psychosis (CHR-P) is highly specific for psychotic disorders other than pluripotential to various serious mental illnesses. However, not all CHR-P develop psychotic disorder only, and psychosis can occur in non-psychotic disorders as well. Our prospective cohort study aims to investigate the characteristics and clinical outcomes of a pluripotent high-risk group with the potential to develop a diverse range of psychiatric disorders. METHODS The SPRIM study is a prospective naturalistic cohort program that focuses on the early detection of those at risk of developing serious mental illness, including psychosis (CHR-P), bipolar (CHR-B), and depressive disorder (CHR-D), as well as undifferentiated risk participants (UCHR). Our study has a longitudinal design with a baseline assessment and eight follow-up evaluations at 6, 12, 18, 24, 30, 36, 42, and 48 months to determine whether participants have transitioned to psychosis or mood disorders. RESULTS The SPRIM sample consisted of 90 CHR participants. The total cumulative incidence rate of transition was 53.3% (95% CI 32.5-77.2). CHR-P, CHR-B, CHR-D, and UCHR had cumulative incidence rates of 13.7% (95% CI 3.4-46.4), 52.4% (95% CI 28.1-81.1), 66.7% (95% CI 24.6-98.6) and 54.3% (95% CI 20.5-93.1), respectively. The cumulative incidence of psychosis, bipolar, and depressive disorder among all participants was 3.3% (95% CI 0.8-11.5), 45.7% (95% CI 24.4-73.6), and 11.2% (95% CI 3.1-36.2), respectively. CONCLUSIONS Our study suggests that the concept of pluripotent high-risk for a diverse range of psychiatric disorders is an integrative approach to examining transdiagnostic interactions between illnesses with a high transition rate and minimizing stigma.
Collapse
Affiliation(s)
- Tae Young Lee
- Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea
| | - Hyunju Lee
- Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea
| | - Junhee Lee
- Department of Psychiatry, Seoul St. Mary's Hospital, Seoul, Republic of Korea
| | - Yunna Lee
- Department of Neuropsychiatry, Kosin University Gospel Hospital, Pusan, Republic of Korea
| | - Sang Jin Rhee
- Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea
| | - Dong Yeon Park
- Department of Psychiatry, National Center for Mental Health, Seoul, Republic of Korea
| | - Myung Jae Paek
- Department of Psychiatry, Kyung Hee University Hospital, Seoul, Republic of Korea
| | - Eun Young Kim
- Seoul National University Health Service Center, Seoul National University, Seoul, Republic of Korea
| | - Euitae Kim
- Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
| | - Sungwon Roh
- Department of Neuropsychiatry, Hanyang University Hospital, Seoul, Republic of Korea
| | - Hee Yeon Jung
- Department of Psychiatry, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea
| | - Minah Kim
- Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea
| | - Se Hyun Kim
- Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea
| | - Yong Min Ahn
- Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea; Department of Psychiatry and Behavioral Science, Seoul National University College of Medicine, Seoul, Republic of Korea; Institute of Human Behavioral Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea.
| | - Kyooseob Ha
- Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada; Department of Psychiatry, Lions Gate Hospital - Vancouver Coastal Health, British Columbia, Canada.
| | - Jun Soo Kwon
- Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea; Department of Psychiatry and Behavioral Science, Seoul National University College of Medicine, Seoul, Republic of Korea; Institute of Human Behavioral Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea
| |
Collapse
|
3
|
Kuehne C, Phillips MD, Moody S, Bryson C, Campbell IC, Conde P, Cummins N, Desrivières S, Dineley J, Dobson R, Douglas D, Folarin A, Gallop L, Hemmings A, İnce B, Mason L, Rashid Z, Bromell A, Sims C, Allen K, Bailie C, Bains P, Basher M, Battisti F, Baudinet J, Bristow K, Dawson N, Dodd L, Frater V, Freudenthal R, Gripton B, Kan C, Khor JWT, Kotze N, Laverack S, Martin L, Maxwell S, McDonald S, McKnight D, McKay R, Merrin J, Nash M, Nicholls D, Palmer S, Pearce S, Roberts C, Serpell L, Severs E, Simic M, Staton A, Westaway S, Sharpe H, Schmidt U, Bartel H, French T, Kelly J, Micali N, Raman S, Treasure J, Malik U, Rabelo-da-Ponte D, Stephens F, Opitz T, Trompeter N, Wilkins J, Parnell T, Abbas R, Bromell A, Davis G, Eadie C, Gracie L, Heslop B, McKenzie K, Odubanjo E, Sims C, Street T, Tavares-Semedo A, Wilkinson E, Zocek L. Characterising illness stages and recovery trajectories of eating disorders in young people via remote measurement technology (STORY): a multi-centre prospective cohort study protocol. BMC Psychiatry 2024; 24:409. [PMID: 38816707 PMCID: PMC11137943 DOI: 10.1186/s12888-024-05841-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/24/2024] [Accepted: 05/13/2024] [Indexed: 06/01/2024] Open
Abstract
BACKGROUND Eating disorders (EDs) are serious, often chronic, conditions associated with pronounced morbidity, mortality, and dysfunction increasingly affecting young people worldwide. Illness progression, stages and recovery trajectories of EDs are still poorly characterised. The STORY study dynamically and longitudinally assesses young people with different EDs (restricting; bingeing/bulimic presentations) and illness durations (earlier; later stages) compared to healthy controls. Remote measurement technology (RMT) with active and passive sensing is used to advance understanding of the heterogeneity of earlier and more progressed clinical presentations and predictors of recovery or relapse. METHODS STORY follows 720 young people aged 16-25 with EDs and 120 healthy controls for 12 months. Online self-report questionnaires regularly assess ED symptoms, psychiatric comorbidities, quality of life, and socioeconomic environment. Additional ongoing monitoring using multi-parametric RMT via smartphones and wearable smart rings ('Ōura ring') unobtrusively measures individuals' daily behaviour and physiology (e.g., Bluetooth connections, sleep, autonomic arousal). A subgroup of participants completes additional in-person cognitive and neuroimaging assessments at study-baseline and after 12 months. DISCUSSION By leveraging these large-scale longitudinal data from participants across ED diagnoses and illness durations, the STORY study seeks to elucidate potential biopsychosocial predictors of outcome, their interplay with developmental and socioemotional changes, and barriers and facilitators of recovery. STORY holds the promise of providing actionable findings that can be translated into clinical practice by informing the development of both early intervention and personalised treatment that is tailored to illness stage and individual circumstances, ultimately disrupting the long-term burden of EDs on individuals and their families.
Collapse
Affiliation(s)
- Carina Kuehne
- Centre for Research in Eating and Weight Disorders, Institute of Psychiatry, King's College London, Psychology & Neuroscience London (IoPPN), 103 Denmark Hill, First Floor, London, SE5 8AZ, UK
| | - Matthew D Phillips
- Centre for Research in Eating and Weight Disorders, Institute of Psychiatry, King's College London, Psychology & Neuroscience London (IoPPN), 103 Denmark Hill, First Floor, London, SE5 8AZ, UK
| | - Sarah Moody
- School of Health in Social Science, The University of Edinburgh, Edinburgh, UK
| | - Callum Bryson
- Centre for Research in Eating and Weight Disorders, Institute of Psychiatry, King's College London, Psychology & Neuroscience London (IoPPN), 103 Denmark Hill, First Floor, London, SE5 8AZ, UK
| | - Iain C Campbell
- Centre for Research in Eating and Weight Disorders, Institute of Psychiatry, King's College London, Psychology & Neuroscience London (IoPPN), 103 Denmark Hill, First Floor, London, SE5 8AZ, UK
| | - Pauline Conde
- Department of Biostatistics & Health Informatics, IoPPN, King's College London, London, UK
| | - Nicholas Cummins
- Department of Biostatistics & Health Informatics, IoPPN, King's College London, London, UK
| | - Sylvane Desrivières
- Social, Genetic & Developmental Psychiatry Centre, IoPPN, King's College London, London, UK
| | - Judith Dineley
- Department of Biostatistics & Health Informatics, IoPPN, King's College London, London, UK
| | - Richard Dobson
- Department of Biostatistics & Health Informatics, IoPPN, King's College London, London, UK
- NIHR Maudsley Biomedical Research Centre, London, UK
- University College London, Institute of Health Informatics, London, UK
| | - Daire Douglas
- Centre for Research in Eating and Weight Disorders, Institute of Psychiatry, King's College London, Psychology & Neuroscience London (IoPPN), 103 Denmark Hill, First Floor, London, SE5 8AZ, UK
| | - Amos Folarin
- Department of Biostatistics & Health Informatics, IoPPN, King's College London, London, UK
- NIHR Maudsley Biomedical Research Centre, London, UK
- University College London, Institute of Health Informatics, London, UK
| | - Lucy Gallop
- Centre for Research in Eating and Weight Disorders, Institute of Psychiatry, King's College London, Psychology & Neuroscience London (IoPPN), 103 Denmark Hill, First Floor, London, SE5 8AZ, UK
| | - Amelia Hemmings
- Centre for Research in Eating and Weight Disorders, Institute of Psychiatry, King's College London, Psychology & Neuroscience London (IoPPN), 103 Denmark Hill, First Floor, London, SE5 8AZ, UK
| | - Başak İnce
- Centre for Research in Eating and Weight Disorders, Institute of Psychiatry, King's College London, Psychology & Neuroscience London (IoPPN), 103 Denmark Hill, First Floor, London, SE5 8AZ, UK
| | - Luke Mason
- Department of Forensic and Neurodevelopmental Science, IoPPN, King's College London, London, UK
| | - Zulqarnain Rashid
- Department of Biostatistics & Health Informatics, IoPPN, King's College London, London, UK
| | | | | | - Karina Allen
- Centre for Research in Eating and Weight Disorders, Institute of Psychiatry, King's College London, Psychology & Neuroscience London (IoPPN), 103 Denmark Hill, First Floor, London, SE5 8AZ, UK
- South London and Maudsley NHS Foundation Trust, London, UK
| | - Chantal Bailie
- Cornwall Partnership NHS Foundation Trus, Bodmin, Cornwall, UK
| | - Parveen Bains
- Oxford Health NHS Foundation Trust, Oxford, Oxfordshire, UK
| | - Mike Basher
- Cambridgeshire and Peterborough NHS Foundation Trust, Fulbourn, Cambridgeshire, UK
| | | | - Julian Baudinet
- Centre for Research in Eating and Weight Disorders, Institute of Psychiatry, King's College London, Psychology & Neuroscience London (IoPPN), 103 Denmark Hill, First Floor, London, SE5 8AZ, UK
- South London and Maudsley NHS Foundation Trust, London, UK
| | - Katherine Bristow
- Cambridgeshire and Peterborough NHS Foundation Trust, Fulbourn, Cambridgeshire, UK
| | - Nicola Dawson
- Bradford District Care NHS Foundation Trust, West Yorkshire, UK
| | - Lizzie Dodd
- South West Yorkshire Partnership NHS Foundation Trust, Wakefield, UK
| | - Victoria Frater
- Cumbria Northumberland Tyne and Wear NHS Foundation Trust, Newcastle Upon Tyne, UK
| | - Robert Freudenthal
- Barnet, Enfield and Haringey Mental Health NHS Foundation Trust, London, UK
| | - Beth Gripton
- Leeds and York Partnership NHS Foundation Trust, Leeds, UK
| | - Carol Kan
- Central and North West London NHS Foundation Trust, London, UK
| | - Joel W T Khor
- South West London & St. George's Mental Health NHS Trust, St George's Eating Disorders Service, London, UK
| | - Nicus Kotze
- Dorset Healthcare University NHS Foundation Trust, Poole, Dorset, UK
| | - Stuart Laverack
- Derbyshire Healthcare NHS Foundation Trust, Derby, Derbyshire, UK
| | - Lee Martin
- Leeds and York Partnership NHS Foundation Trust, Leeds, UK
| | - Sarah Maxwell
- Norfolk and Suffolk NHS Foundation Trust, Norwich, Norfolk, UK
| | - Sarah McDonald
- Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK
| | - Delysia McKnight
- North Staffordshire Combined Healthcare NHS Trust; Trentham, Staffordshire, UK
| | | | - Jessica Merrin
- South West Yorkshire Partnership NHS Foundation Trust, Wakefield, UK
| | - Mel Nash
- Devon Partnership NHS Foundation Trust, Exeter, Devon, UK
| | - Dasha Nicholls
- Central and North West London NHS Foundation Trust, London, UK
- Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK
| | | | - Samantha Pearce
- Cornwall Partnership NHS Foundation Trus, Bodmin, Cornwall, UK
| | | | - Lucy Serpell
- North East London NHS Foundation Trust, London, UK
- Division of Psychology and Language Sciences, University College London, London, UK
| | | | - Mima Simic
- South London and Maudsley NHS Foundation Trust, London, UK
| | - Amelia Staton
- Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, UK
| | - Sian Westaway
- Herefordshire and Worcestershire Health and Care NHS Trust, Worcester, UK
| | - Helen Sharpe
- School of Health in Social Science, The University of Edinburgh, Edinburgh, UK
| | - Ulrike Schmidt
- Centre for Research in Eating and Weight Disorders, Institute of Psychiatry, King's College London, Psychology & Neuroscience London (IoPPN), 103 Denmark Hill, First Floor, London, SE5 8AZ, UK.
- South London and Maudsley NHS Foundation Trust, London, UK.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Arribas M, Oliver D, Patel R, Kornblum D, Shetty H, Damiani S, Krakowski K, Provenzani U, Stahl D, Koutsouleris N, McGuire P, Fusar-Poli P. A transdiagnostic prodrome for severe mental disorders: an electronic health record study. Mol Psychiatry 2024:10.1038/s41380-024-02533-5. [PMID: 38710907 DOI: 10.1038/s41380-024-02533-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/22/2023] [Revised: 03/08/2024] [Accepted: 03/13/2024] [Indexed: 05/08/2024]
Abstract
Effective prevention of severe mental disorders (SMD), including non-psychotic unipolar mood disorders (UMD), non-psychotic bipolar mood disorders (BMD), and psychotic disorders (PSY), rely on accurate knowledge of the duration, first presentation, time course and transdiagnosticity of their prodromal stages. Here we present a retrospective, real-world, cohort study using electronic health records, adhering to RECORD guidelines. Natural language processing algorithms were used to extract monthly occurrences of 65 prodromal features (symptoms and substance use), grouped into eight prodromal clusters. The duration, first presentation, and transdiagnosticity of the prodrome were compared between SMD groups with one-way ANOVA, Cohen's f and d. The time course (mean occurrences) of prodromal clusters was compared between SMD groups with linear mixed-effects models. 26,975 individuals diagnosed with ICD-10 SMD were followed up for up to 12 years (UMD = 13,422; BMD = 2506; PSY = 11,047; median[IQR] age 39.8[23.7] years; 55% female; 52% white). The duration of the UMD prodrome (18[36] months) was shorter than BMD (26[35], d = 0.21) and PSY (24[38], d = 0.18). Most individuals presented with multiple first prodromal clusters, with the most common being non-specific ('other'; 88% UMD, 85% BMD, 78% PSY). The only first prodromal cluster that showed a medium-sized difference between the three SMD groups was positive symptoms (f = 0.30). Time course analysis showed an increase in prodromal cluster occurrences approaching SMD onset. Feature occurrence across the prodromal period showed small/negligible differences between SMD groups, suggesting that most features are transdiagnostic, except for positive symptoms (e.g. paranoia, f = 0.40). Taken together, our findings show minimal differences in the duration and first presentation of the SMD prodromes as recorded in secondary mental health care. All the prodromal clusters intensified as individuals approached SMD onset, and all the prodromal features other than positive symptoms are transdiagnostic. These results support proposals to develop transdiagnostic preventive services for affective and psychotic disorders detected in secondary mental healthcare.
Collapse
Affiliation(s)
- Maite Arribas
- Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 8AF, UK.
| | - Dominic Oliver
- Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 8AF, UK
- Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK
- NIHR Oxford Health Biomedical Research Centre, Oxford, OX3 7JX, UK
- OPEN Early Detection Service, Oxford Health NHS Foundation Trust, Oxford, OX3 7JX, UK
| | - Rashmi Patel
- Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 8AF, UK
| | | | - Hitesh Shetty
- NIHR Maudsley Biomedical Research Centre, London, UK
| | - Stefano Damiani
- Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
| | - Kamil Krakowski
- Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 8AF, UK
- Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
| | - Umberto Provenzani
- Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
| | - Daniel Stahl
- NIHR Maudsley Biomedical Research Centre, London, UK
- Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, London, SE5 8AF, UK
| | - Nikolaos Koutsouleris
- Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, UK
- Department of Psychiatry and Psychotherapy, Ludwig-Maximilian University, Munich, Germany
- Max-Planck Institute of Psychiatry, Munich, Germany
| | - Philip McGuire
- Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK
- NIHR Oxford Health Biomedical Research Centre, Oxford, OX3 7JX, UK
- OPEN Early Detection Service, Oxford Health NHS Foundation Trust, Oxford, OX3 7JX, UK
| | - Paolo Fusar-Poli
- Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 8AF, UK
- Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
- Department of Psychiatry and Psychotherapy, Ludwig-Maximilian University, Munich, Germany
- Outreach and Support in South-London (OASIS) Service, South London and Maudsley (SLaM) NHS Foundation Trust, London, SE11 5DL, UK
| |
Collapse
|
5
|
Oliver D, Chesney E, Cullen AE, Davies C, Englund A, Gifford G, Kerins S, Lalousis PA, Logeswaran Y, Merritt K, Zahid U, Crossley NA, McCutcheon RA, McGuire P, Fusar-Poli P. Exploring causal mechanisms of psychosis risk. Neurosci Biobehav Rev 2024; 162:105699. [PMID: 38710421 DOI: 10.1016/j.neubiorev.2024.105699] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2023] [Revised: 02/17/2024] [Accepted: 04/28/2024] [Indexed: 05/08/2024]
Abstract
Robust epidemiological evidence of risk and protective factors for psychosis is essential to inform preventive interventions. Previous evidence syntheses have classified these risk and protective factors according to their strength of association with psychosis. In this critical review we appraise the distinct and overlapping mechanisms of 25 key environmental risk factors for psychosis, and link these to mechanistic pathways that may contribute to neurochemical alterations hypothesised to underlie psychotic symptoms. We then discuss the implications of our findings for future research, specifically considering interactions between factors, exploring universal and subgroup-specific factors, improving understanding of temporality and risk dynamics, standardising operationalisation and measurement of risk and protective factors, and developing preventive interventions targeting risk and protective factors.
Collapse
Affiliation(s)
- Dominic Oliver
- Department of Psychiatry, University of Oxford, Oxford, UK; NIHR Oxford Health Biomedical Research Centre, Oxford, UK; OPEN Early Detection Service, Oxford Health NHS Foundation Trust, Oxford, UK; Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
| | - Edward Chesney
- Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Addictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 4 Windsor Walk, London SE5 8AF, UK
| | - Alexis E Cullen
- Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Department of Clinical Neuroscience, Karolinska Institutet, Sweden
| | - Cathy Davies
- Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
| | - Amir Englund
- Addictions Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 4 Windsor Walk, London SE5 8AF, UK
| | - George Gifford
- Department of Psychiatry, University of Oxford, Oxford, UK
| | - Sarah Kerins
- Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
| | - Paris Alexandros Lalousis
- Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Munich, Germany
| | - Yanakan Logeswaran
- Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Department of Biostatistics & Health Informatics, King's College London, London, UK
| | - Kate Merritt
- Division of Psychiatry, Institute of Mental Health, UCL, London, UK
| | - Uzma Zahid
- Department of Psychology, King's College London, London, UK
| | - Nicolas A Crossley
- Department of Psychiatry, University of Oxford, Oxford, UK; Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Chile
| | - Robert A McCutcheon
- Department of Psychiatry, University of Oxford, Oxford, UK; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Oxford Health NHS Foundation Trust, Oxford, UK
| | - Philip McGuire
- Department of Psychiatry, University of Oxford, Oxford, UK; NIHR Oxford Health Biomedical Research Centre, Oxford, UK; OPEN Early Detection Service, Oxford Health NHS Foundation Trust, Oxford, UK
| | - Paolo Fusar-Poli
- Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK; Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Munich, Germany; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; OASIS Service, South London and Maudsley NHS Foundation Trust, London SE11 5DL, UK
| |
Collapse
|
6
|
Takahashi T, Katagiri N, Higuchi Y, Nishiyama S, Arai Y, Tagata H, Lavoie S, McGorry PD, Nelson B, Yung AR, Boldrini T, Nemoto T, Mizuno M, Suzuki M, Polari A. Nomenclature for psychosis risk in Japan: Survey results from high-risk individuals, caregivers, and mental health professionals. Schizophr Res 2024; 267:373-380. [PMID: 38631112 DOI: 10.1016/j.schres.2024.04.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/04/2024] [Revised: 03/09/2024] [Accepted: 04/08/2024] [Indexed: 04/19/2024]
Abstract
BACKGROUND Labeling terms for high-risk state for psychosis, such as 'ultra-high risk' (UHR), 'attenuated psychosis syndrome' (APS), and 'at-risk mental state' (ARMS), have been criticized for their potential to lead to stigma. Hence, mental health service users in Melbourne recently proposed new terms illustrating the at-risk concept ['pre-diagnosis stage' (PDS), 'potential of developing a mental illness' (PDMI), and 'disposition for developing a mental illness' (DDMI)]. We aimed at testing the suitability of these existing and new terms in the clinical settings of early psychiatric intervention in Japan. METHODS At two centers of early intervention (Toyama and Tokyo), a questionnaire on the understanding and opinion of high-risk terminology was administered to 62 high-risk patients, 44 caregivers, and 64 clinicians. The questionnaire contained the existing and new terms, where the term ARMS was translated into two different Japanese terms ARMS-psychosis and ARMS-kokoro. Participants' opinion on the disclosure of high-risk status was also obtained. RESULTS ARMS-kokoro was most preferred, least stigmatizing, and best explaining the patients' difficulties for all groups, while UHR and other terms including the Japanese word 'psychosis' (i.e., APS and ARMS-psychosis) were not preferred. New labeling terms were generally not well received. All groups preferred full disclosure of high-risk terms by the psychiatrist with or without the presence of family members. CONCLUSION The term ARMS-kokoro was commonly accepted as a favorable labeling term for the high-risk state for psychosis in Japan. However, another translation ARMS-psychosis was considered stigmatizing, demonstrating the importance of appropriate translation of high-risk terminology into local languages.
Collapse
Affiliation(s)
- Tsutomu Takahashi
- Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan; Research Center for Idling Brain Science, University of Toyama, Toyama, Japan.
| | - Naoyuki Katagiri
- Department of Neuropsychiatry, School of Medicine, Toho University, Tokyo, Japan
| | - Yuko Higuchi
- Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan; Research Center for Idling Brain Science, University of Toyama, Toyama, Japan
| | - Shimako Nishiyama
- Health Administration Center, Faculty of Education and Research Promotion, Academic Assembly, University of Toyama, Toyama, Japan
| | - Yu Arai
- Department of Neuropsychiatry, School of Medicine, Toho University, Tokyo, Japan
| | - Hiromi Tagata
- Department of Neuropsychiatry, School of Medicine, Toho University, Tokyo, Japan
| | - Suzie Lavoie
- Orygen, Parkville, Victoria, Australia; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia
| | - Patrick D McGorry
- Orygen, Parkville, Victoria, Australia; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia
| | - Barnaby Nelson
- Orygen, Parkville, Victoria, Australia; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia
| | - Alison R Yung
- Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Geelong, VIC, Australia
| | - Tommaso Boldrini
- Department of Developmental Psychology and Socialization, University of Padova, Padova, Italy
| | - Takahiro Nemoto
- Department of Neuropsychiatry, School of Medicine, Toho University, Tokyo, Japan
| | - Masafumi Mizuno
- Department of Neuropsychiatry, School of Medicine, Toho University, Tokyo, Japan; Tokyo Metropolitan Matsuzawa Hospital, Tokyo, Japan
| | - Michio Suzuki
- Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan; Research Center for Idling Brain Science, University of Toyama, Toyama, Japan
| | - Andrea Polari
- Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia; Orygen Specialist Program, Parkville, Victoria, Australia
| |
Collapse
|
7
|
Díaz-Caneja CM, Guloksuz S. The why and the how of transdiagnostic clinical research in youth psychiatry. Eur Neuropsychopharmacol 2024; 82:55-56. [PMID: 38490086 DOI: 10.1016/j.euroneuro.2024.02.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/15/2024] [Revised: 02/13/2024] [Accepted: 02/15/2024] [Indexed: 03/17/2024]
Affiliation(s)
- Covadonga M Díaz-Caneja
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, Instituto de Salud Carlos III, School of Medicine, Universidad Complutense, Madrid, Spain.
| | - Sinan Guloksuz
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
| |
Collapse
|
8
|
Shah JL, Paquin V, McIlwaine SV, Malla AK, Joober R, Pruessner M. Examining the psychobiological response to acute social stress across clinical stages and symptom trajectories in the early psychosis continuum. Dev Psychopathol 2024; 36:774-786. [PMID: 36852607 DOI: 10.1017/s0954579423000056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
The stress-vulnerability model has been repeatedly highlighted in relation to the risk, onset and course of psychosis, and has been independently studied in clinical high-risk (CHR) and first-episode psychosis (FEP) populations. Notable in this literature, however, is that there are few studies directly comparing markers of stress response across progressive stages of illness. Here we examined the psychobiological response to the Trier Social Stress Test in 28 CHR (mean age 19.1) and 61 FEP (age 23.0) patients, in order to understand the stage(s) or trajectories in which differences in subjective stress or physiological response occur. The overall clinical sample had greater perceived stress and blunted cortisol (FEP + CHR, n = 89, age 21.7) compared with healthy controls (n = 45, age 22.9). Additional analyses demonstrated elevated heart rate and systolic blood pressure in FEP compared with CHR, but there were no further differences in physiological parameters (cortisol, heart rate, or blood pressure) between stage- or trajectory-based groups. Together, this suggests that individual stress response markers may differentially emerge at particular stages en route to psychosis - and demonstrates how stage-based analyses can shed light on the emergence and evolution of neurobiological changes in mental illness.
Collapse
Affiliation(s)
- Jai L Shah
- Department of Psychiatry, McGill University, Montreal, Canada
| | - Vincent Paquin
- Department of Psychiatry, McGill University, Montreal, Canada
| | - Sarah V McIlwaine
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada
| | - Ashok K Malla
- Department of Psychiatry, McGill University, Montreal, Canada
| | - Ridha Joober
- Department of Psychiatry, McGill University, Montreal, Canada
| | | |
Collapse
|
9
|
Paquin V, Ferrari M, Rej S, Boivin M, Ouellet-Morin I, Geoffroy MC, Shah JL. Trajectories of Adolescent Media Use and Their Associations With Psychotic Experiences. JAMA Psychiatry 2024:2817594. [PMID: 38598210 PMCID: PMC11007660 DOI: 10.1001/jamapsychiatry.2024.0384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/03/2023] [Accepted: 02/04/2024] [Indexed: 04/11/2024]
Abstract
Importance Adolescent media use is thought to influence mental health, but whether it is associated with psychotic experiences (PEs) is unclear. Objective To examine longitudinal trajectories of adolescent media use and their associations with PEs at 23 years of age. Design, Setting, and Participants This cohort study included participants from the Québec Longitudinal Study of Child Development (1998-2021): children who were born in Québec, Canada, and followed up annually or biennially from ages 5 months through 23 years. Data were analyzed between January 2023 and January 2024. Exposures Participants reported their weekly amount of television viewing, video gaming, computer use, and reading at ages 12, 13, 15, and 17 years. Main Outcome and Measures Lifetime occurrence of PEs was measured at 23 years of age. Covariables included sociodemographic, genetic, family, and childhood characteristics between ages 5 months and 12 years. Results A total of 1226 participants were included in the analyses (713 [58.2%] female, 513 [41.8%] male). For each media type, latent class mixed modeling identified 3 group-based trajectories, with subgroups following trajectories of higher use: television viewing, 128 (10.4%); video gaming, 145 (11.8%); computer use, 353 (28.8%); and reading, 140 (11.4%). Relative to lower video gaming, higher video gaming was preceded by higher levels of mental health and interpersonal problems at age 12 years. Adjusting for these risk factors mitigated the association between higher video gaming and PEs at age 23 years. The curved trajectory of computer use (189 [15.4%] participants), characterized by increasing levels of use until age 15 years followed by a decrease, was associated with higher PEs (estimated difference, +5.3%; 95% CI, +1.5% to +9.3%) relative to lower use (684 [55.8%] participants). This association remained statistically significant after covariable adjustment. Conclusions and Relevance This study found that longitudinal trajectories of media use during adolescence were modestly associated with PEs at age 23 years, likely reflecting the influence of shared risk factors. Understanding the environmental determinants and psychosocial functions of media use during adolescence may help better integrate digital technologies in the prevention and management of PEs.
Collapse
Affiliation(s)
- Vincent Paquin
- Department of Psychiatry, McGill University, Montreal, Quebec, Canada
- Douglas Mental Health University Institute, Montreal, Quebec, Canada
- Lady Davis Research Institute, Jewish General Hospital, Montreal, Quebec, Canada
| | - Manuela Ferrari
- Department of Psychiatry, McGill University, Montreal, Quebec, Canada
- Douglas Mental Health University Institute, Montreal, Quebec, Canada
| | - Soham Rej
- Department of Psychiatry, McGill University, Montreal, Quebec, Canada
- Lady Davis Research Institute, Jewish General Hospital, Montreal, Quebec, Canada
| | - Michel Boivin
- School of Psychology, Laval University, Quebec City, Quebec, Canada
| | - Isabelle Ouellet-Morin
- School of Criminology, University of Montreal, Montreal, Quebec, Canada
- Research Center of the Montreal Mental Health University Institute, Montreal, Quebec, Canada
| | - Marie-Claude Geoffroy
- Department of Psychiatry, McGill University, Montreal, Quebec, Canada
- Douglas Mental Health University Institute, Montreal, Quebec, Canada
| | - Jai L. Shah
- Department of Psychiatry, McGill University, Montreal, Quebec, Canada
- Douglas Mental Health University Institute, Montreal, Quebec, Canada
| |
Collapse
|
10
|
Nkire N, Kinsella A, Russell V, Waddington JL. Duration of the psychosis prodrome and its relationship to duration of untreated psychosis across all 12 DSM-IV psychotic diagnoses: Evidence for a trans-diagnostic process associated with resilience. Eur Neuropsychopharmacol 2024; 80:5-13. [PMID: 38128335 DOI: 10.1016/j.euroneuro.2023.12.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Revised: 12/04/2023] [Accepted: 12/14/2023] [Indexed: 12/23/2023]
Abstract
While duration of the psychosis prodrome (DPP) attracts attention in relation to the developmental trajectory of psychotic illness and service models, fundamental issues endure in the context of dimensional-spectrum models of psychosis. Among 205 epidemiologically representative subjects in the Cavan-Monaghan First Episode Psychosis Study, DPP was systematically quantified and compared, for the first time, across all 12 DSM-IV psychotic diagnoses. DPP was also compared with duration of untreated psychosis (DUP) and each was then analysed in relation to premorbid features across three age ranges: <12, 12-15 and 16-18 years. For each diagnosis, medians for both DPP and DUP were shorter than means, indicating common right-skewed distributions. Rank orders for both DPP and DUP were longest for schizophrenia, intermediate for other schizophrenia-spectrum psychoses, psychotic depression and psychotic disorder not otherwise specified, and shortest for brief psychotic disorder, bipolar disorder and substance-induced psychotic disorder, though with overlapping right-skewed distributions. DPP was longer than DUP for all diagnoses except substance-induced psychotic disorder. Across functional psychotic diagnoses, longer DPP was predicted by higher premorbid intelligence and better premorbid adjustment during age 16-18 years. These findings indicate that, trans-diagnostically, DPP and DUP share right-skewed continuities, in accordance with a dimensional-spectrum model of psychotic illness, and may reflect a unitary process that has been dichotomized at a subjective threshold along its trajectory. Better premorbid functioning during age 16-18 years appears to confer resilience by delaying progression to overt psychotic symptoms and may constitute a particular target period for psychosocial interventions.
Collapse
Affiliation(s)
- Nnamdi Nkire
- Drumalee Primary Care Centre, Cavan-Monaghan Mental Health Service, Cavan, Ireland; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland
| | - Anthony Kinsella
- School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland
| | - Vincent Russell
- Drumalee Primary Care Centre, Cavan-Monaghan Mental Health Service, Cavan, Ireland; Department of Psychiatry, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin, Ireland
| | - John L Waddington
- School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland; Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psychiatric-Disorders and Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, China.
| |
Collapse
|
11
|
Youn S, Guadagno BL, Byrne LK, Watson AE, Murrihy S, Cotton SM. Systematic Review and Meta-analysis: Rates of Violence During First-Episode Psychosis (FEP). Schizophr Bull 2024:sbae010. [PMID: 38412435 DOI: 10.1093/schbul/sbae010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/29/2024]
Abstract
BACKGROUND Most people with psychotic disorders will never commit an act of violence. However, the risk of violence committed by people with schizophrenia is higher than the general population. Violence risk is also known to be highest during the first episode of psychosis compared to later stages of illness. Despite this, there have been no comprehensive reviews conducted in the past 10 years examining rates of violence during FEP. We aimed to provide an updated review of the rate of violence in people with FEP. STUDY DESIGN Meta-analytical techniques were used to identify pooled proportions of violence according to severity (less serious, serious, severe) and timing of violence (before presentation, at first presentation, after presentation to services). STUDY RESULTS Twenty-two studies were included. The pooled prevalence was 13.4% (95% CI [9.0%-19.5%]) for any violence, 16.3% (95% CI [9.1%-27.4%]) for less serious violence, 9.7% (95% CI [5.4%-17.0%]) for serious violence and 2.7% for severe violence, regardless of time point. The pooled prevalence of any violence was 11.6% (95% CI [6.8%-18.9%]) before presentation, 20.8% (95% CI [9.8%-38.7%]) at first presentation and 13.3% (95% CI [7.3%-23.0%]) after presentation to services. CONCLUSION Overall, rates of violence appear to be lower in more recent years. However, due to the high between-study heterogeneity related to study design, the findings must be interpreted with consideration of sample characteristics and other contextual factors. The prevalence of violence remained high at all-time points, suggesting that more targeted, holistic, and early interventions are needed for clinical FEP groups.
Collapse
Affiliation(s)
- Sarah Youn
- Orygen, 35 Poplar Road, Parkville, Melbourne, Victoria 3052, Australia
- Centre for Youth Mental Health, The University of Melbourne, 35 Poplar Road, Parkville, Melbourne, Victoria 3052, Australia
- School of Psychology, Deakin University, 1 Gheringhap Street, Geelong, Victoria 3220, Australia
| | - Belinda L Guadagno
- School of Psychology, Deakin University, 1 Gheringhap Street, Geelong, Victoria 3220, Australia
| | - Linda K Byrne
- School of Psychology, Deakin University, 1 Gheringhap Street, Geelong, Victoria 3220, Australia
- Faculty of Psychology, Counselling and Psychotherapy, The Cairnmillar Institute, 391-393 Tooroonga Road, Hawthorn East, Victoria 3123, Australia
| | - Amity E Watson
- Orygen, 35 Poplar Road, Parkville, Melbourne, Victoria 3052, Australia
- Centre for Youth Mental Health, The University of Melbourne, 35 Poplar Road, Parkville, Melbourne, Victoria 3052, Australia
| | - Sean Murrihy
- Orygen, 35 Poplar Road, Parkville, Melbourne, Victoria 3052, Australia
- Centre for Youth Mental Health, The University of Melbourne, 35 Poplar Road, Parkville, Melbourne, Victoria 3052, Australia
- Melbourne School of Psychological Sciences, The University of Melbourne, Parkville, Melbourne, Victoria 3010, Australia
| | - Sue M Cotton
- Orygen, 35 Poplar Road, Parkville, Melbourne, Victoria 3052, Australia
- Centre for Youth Mental Health, The University of Melbourne, 35 Poplar Road, Parkville, Melbourne, Victoria 3052, Australia
| |
Collapse
|
12
|
Jordan G, Bassetto S, DeLuca J, Dobbs MF, Florence A, Allemang B, O'Keeffe D, Basile M, Funaro MC, Davidson L, Ben-David S, Shah J. Personal Recovery Among People at Risk for Developing Serious Mental Health Problems: A Qualitative Systematic Review. Psychiatr Serv 2024:appips20230133. [PMID: 38410038 DOI: 10.1176/appi.ps.20230133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/28/2024]
Abstract
OBJECTIVE Personal recovery refers to a person's pursuit of a full, meaningful life despite the potentially debilitating impact of a mental illness. An evidence base describing personal recovery among people at risk for developing a mental illness is lacking, limiting the potential for mental health services to support personal recovery. To address this gap, the authors synthesized the extant research describing personal recovery among people at risk for developing a mental illness. METHODS A systematic search of several literature databases (MEDLINE, Embase, APA PsycInfo, Web of Science Core Collection, and Cochrane Library) was conducted to retrieve qualitative and case studies and first-person accounts. The Joanna Briggs Institute guidelines for systematic reviews were followed. Included studies reported on participants at variable risk for developing a schizophrenia spectrum, bipolar, major depressive, or borderline personality disorder. Articles were retrieved through a librarian-assisted search and through use of additional strategies (e.g., expert consultation). Abstracts were screened by the research team, and themes were developed by using thematic synthesis. RESULTS The 36 included articles were synthesized, and six themes were generated: difficulties and challenges; establishing an understanding of, and finding ways to cope with, one's mental health challenges; reestablishing a sense of agency and personhood; receiving support from people and services, as well as restoring relationships; reestablishing hope, meaning, and purpose; and overcoming stigma and destigmatizing mental illness in others. CONCLUSIONS These findings provide a conceptual foundation that can guide future research on personal recovery and clinical interventions that foster it among people at risk for mental illness.
Collapse
Affiliation(s)
- Gerald Jordan
- Institute for Mental Health, Centre for Urban Wellbeing, School of Psychology, University of Birmingham, Birmingham, United Kingdom (Jordan); Department of Psychiatry, McGill University, Montreal (Bassetto, Shah); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City (DeLuca, Dobbs); Department of Psychological & Brain Sciences, Fairfield University, Fairfield, Connecticut (DeLuca); New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York City (Florence); Faculty of Social Work, University of Calgary, Calgary, Canada (Allemang); ARCHES Recovery College, Mental Health Ireland, Dublin (Ó'Keeffe); School of Social Work, University of British Columbia, Kelowna, Canada (Basile, Ben-David); Harvey Cushing/John Hay Whitney Medical Library (Funaro) and Yale Program for Recovery and Community Health, Department of Psychiatry (Davidson), Yale University, New Haven
| | - Stella Bassetto
- Institute for Mental Health, Centre for Urban Wellbeing, School of Psychology, University of Birmingham, Birmingham, United Kingdom (Jordan); Department of Psychiatry, McGill University, Montreal (Bassetto, Shah); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City (DeLuca, Dobbs); Department of Psychological & Brain Sciences, Fairfield University, Fairfield, Connecticut (DeLuca); New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York City (Florence); Faculty of Social Work, University of Calgary, Calgary, Canada (Allemang); ARCHES Recovery College, Mental Health Ireland, Dublin (Ó'Keeffe); School of Social Work, University of British Columbia, Kelowna, Canada (Basile, Ben-David); Harvey Cushing/John Hay Whitney Medical Library (Funaro) and Yale Program for Recovery and Community Health, Department of Psychiatry (Davidson), Yale University, New Haven
| | - Joseph DeLuca
- Institute for Mental Health, Centre for Urban Wellbeing, School of Psychology, University of Birmingham, Birmingham, United Kingdom (Jordan); Department of Psychiatry, McGill University, Montreal (Bassetto, Shah); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City (DeLuca, Dobbs); Department of Psychological & Brain Sciences, Fairfield University, Fairfield, Connecticut (DeLuca); New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York City (Florence); Faculty of Social Work, University of Calgary, Calgary, Canada (Allemang); ARCHES Recovery College, Mental Health Ireland, Dublin (Ó'Keeffe); School of Social Work, University of British Columbia, Kelowna, Canada (Basile, Ben-David); Harvey Cushing/John Hay Whitney Medical Library (Funaro) and Yale Program for Recovery and Community Health, Department of Psychiatry (Davidson), Yale University, New Haven
| | - Matthew F Dobbs
- Institute for Mental Health, Centre for Urban Wellbeing, School of Psychology, University of Birmingham, Birmingham, United Kingdom (Jordan); Department of Psychiatry, McGill University, Montreal (Bassetto, Shah); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City (DeLuca, Dobbs); Department of Psychological & Brain Sciences, Fairfield University, Fairfield, Connecticut (DeLuca); New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York City (Florence); Faculty of Social Work, University of Calgary, Calgary, Canada (Allemang); ARCHES Recovery College, Mental Health Ireland, Dublin (Ó'Keeffe); School of Social Work, University of British Columbia, Kelowna, Canada (Basile, Ben-David); Harvey Cushing/John Hay Whitney Medical Library (Funaro) and Yale Program for Recovery and Community Health, Department of Psychiatry (Davidson), Yale University, New Haven
| | - Ana Florence
- Institute for Mental Health, Centre for Urban Wellbeing, School of Psychology, University of Birmingham, Birmingham, United Kingdom (Jordan); Department of Psychiatry, McGill University, Montreal (Bassetto, Shah); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City (DeLuca, Dobbs); Department of Psychological & Brain Sciences, Fairfield University, Fairfield, Connecticut (DeLuca); New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York City (Florence); Faculty of Social Work, University of Calgary, Calgary, Canada (Allemang); ARCHES Recovery College, Mental Health Ireland, Dublin (Ó'Keeffe); School of Social Work, University of British Columbia, Kelowna, Canada (Basile, Ben-David); Harvey Cushing/John Hay Whitney Medical Library (Funaro) and Yale Program for Recovery and Community Health, Department of Psychiatry (Davidson), Yale University, New Haven
| | - Brooke Allemang
- Institute for Mental Health, Centre for Urban Wellbeing, School of Psychology, University of Birmingham, Birmingham, United Kingdom (Jordan); Department of Psychiatry, McGill University, Montreal (Bassetto, Shah); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City (DeLuca, Dobbs); Department of Psychological & Brain Sciences, Fairfield University, Fairfield, Connecticut (DeLuca); New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York City (Florence); Faculty of Social Work, University of Calgary, Calgary, Canada (Allemang); ARCHES Recovery College, Mental Health Ireland, Dublin (Ó'Keeffe); School of Social Work, University of British Columbia, Kelowna, Canada (Basile, Ben-David); Harvey Cushing/John Hay Whitney Medical Library (Funaro) and Yale Program for Recovery and Community Health, Department of Psychiatry (Davidson), Yale University, New Haven
| | - Donal O'Keeffe
- Institute for Mental Health, Centre for Urban Wellbeing, School of Psychology, University of Birmingham, Birmingham, United Kingdom (Jordan); Department of Psychiatry, McGill University, Montreal (Bassetto, Shah); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City (DeLuca, Dobbs); Department of Psychological & Brain Sciences, Fairfield University, Fairfield, Connecticut (DeLuca); New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York City (Florence); Faculty of Social Work, University of Calgary, Calgary, Canada (Allemang); ARCHES Recovery College, Mental Health Ireland, Dublin (Ó'Keeffe); School of Social Work, University of British Columbia, Kelowna, Canada (Basile, Ben-David); Harvey Cushing/John Hay Whitney Medical Library (Funaro) and Yale Program for Recovery and Community Health, Department of Psychiatry (Davidson), Yale University, New Haven
| | - Mikaela Basile
- Institute for Mental Health, Centre for Urban Wellbeing, School of Psychology, University of Birmingham, Birmingham, United Kingdom (Jordan); Department of Psychiatry, McGill University, Montreal (Bassetto, Shah); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City (DeLuca, Dobbs); Department of Psychological & Brain Sciences, Fairfield University, Fairfield, Connecticut (DeLuca); New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York City (Florence); Faculty of Social Work, University of Calgary, Calgary, Canada (Allemang); ARCHES Recovery College, Mental Health Ireland, Dublin (Ó'Keeffe); School of Social Work, University of British Columbia, Kelowna, Canada (Basile, Ben-David); Harvey Cushing/John Hay Whitney Medical Library (Funaro) and Yale Program for Recovery and Community Health, Department of Psychiatry (Davidson), Yale University, New Haven
| | - Melissa C Funaro
- Institute for Mental Health, Centre for Urban Wellbeing, School of Psychology, University of Birmingham, Birmingham, United Kingdom (Jordan); Department of Psychiatry, McGill University, Montreal (Bassetto, Shah); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City (DeLuca, Dobbs); Department of Psychological & Brain Sciences, Fairfield University, Fairfield, Connecticut (DeLuca); New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York City (Florence); Faculty of Social Work, University of Calgary, Calgary, Canada (Allemang); ARCHES Recovery College, Mental Health Ireland, Dublin (Ó'Keeffe); School of Social Work, University of British Columbia, Kelowna, Canada (Basile, Ben-David); Harvey Cushing/John Hay Whitney Medical Library (Funaro) and Yale Program for Recovery and Community Health, Department of Psychiatry (Davidson), Yale University, New Haven
| | - Larry Davidson
- Institute for Mental Health, Centre for Urban Wellbeing, School of Psychology, University of Birmingham, Birmingham, United Kingdom (Jordan); Department of Psychiatry, McGill University, Montreal (Bassetto, Shah); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City (DeLuca, Dobbs); Department of Psychological & Brain Sciences, Fairfield University, Fairfield, Connecticut (DeLuca); New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York City (Florence); Faculty of Social Work, University of Calgary, Calgary, Canada (Allemang); ARCHES Recovery College, Mental Health Ireland, Dublin (Ó'Keeffe); School of Social Work, University of British Columbia, Kelowna, Canada (Basile, Ben-David); Harvey Cushing/John Hay Whitney Medical Library (Funaro) and Yale Program for Recovery and Community Health, Department of Psychiatry (Davidson), Yale University, New Haven
| | - Shelly Ben-David
- Institute for Mental Health, Centre for Urban Wellbeing, School of Psychology, University of Birmingham, Birmingham, United Kingdom (Jordan); Department of Psychiatry, McGill University, Montreal (Bassetto, Shah); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City (DeLuca, Dobbs); Department of Psychological & Brain Sciences, Fairfield University, Fairfield, Connecticut (DeLuca); New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York City (Florence); Faculty of Social Work, University of Calgary, Calgary, Canada (Allemang); ARCHES Recovery College, Mental Health Ireland, Dublin (Ó'Keeffe); School of Social Work, University of British Columbia, Kelowna, Canada (Basile, Ben-David); Harvey Cushing/John Hay Whitney Medical Library (Funaro) and Yale Program for Recovery and Community Health, Department of Psychiatry (Davidson), Yale University, New Haven
| | - Jai Shah
- Institute for Mental Health, Centre for Urban Wellbeing, School of Psychology, University of Birmingham, Birmingham, United Kingdom (Jordan); Department of Psychiatry, McGill University, Montreal (Bassetto, Shah); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City (DeLuca, Dobbs); Department of Psychological & Brain Sciences, Fairfield University, Fairfield, Connecticut (DeLuca); New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York City (Florence); Faculty of Social Work, University of Calgary, Calgary, Canada (Allemang); ARCHES Recovery College, Mental Health Ireland, Dublin (Ó'Keeffe); School of Social Work, University of British Columbia, Kelowna, Canada (Basile, Ben-David); Harvey Cushing/John Hay Whitney Medical Library (Funaro) and Yale Program for Recovery and Community Health, Department of Psychiatry (Davidson), Yale University, New Haven
| |
Collapse
|
13
|
Oliver D, Arribas M, Perry BI, Whiting D, Blackman G, Krakowski K, Seyedsalehi A, Osimo EF, Griffiths SL, Stahl D, Cipriani A, Fazel S, Fusar-Poli P, McGuire P. Using Electronic Health Records to Facilitate Precision Psychiatry. Biol Psychiatry 2024:S0006-3223(24)01107-7. [PMID: 38408535 DOI: 10.1016/j.biopsych.2024.02.1006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/16/2023] [Revised: 01/30/2024] [Accepted: 02/21/2024] [Indexed: 02/28/2024]
Abstract
The use of clinical prediction models to produce individualized risk estimates can facilitate the implementation of precision psychiatry. As a source of data from large, clinically representative patient samples, electronic health records (EHRs) provide a platform to develop and validate clinical prediction models, as well as potentially implement them in routine clinical care. The current review describes promising use cases for the application of precision psychiatry to EHR data and considers their performance in terms of discrimination (ability to separate individuals with and without the outcome) and calibration (extent to which predicted risk estimates correspond to observed outcomes), as well as their potential clinical utility (weighing benefits and costs associated with the model compared to different approaches across different assumptions of the number needed to test). We review 4 externally validated clinical prediction models designed to predict psychosis onset, psychotic relapse, cardiometabolic morbidity, and suicide risk. We then discuss the prospects for clinically implementing these models and the potential added value of integrating data from evidence syntheses, standardized psychometric assessments, and biological data into EHRs. Clinical prediction models can utilize routinely collected EHR data in an innovative way, representing a unique opportunity to inform real-world clinical decision making. Combining data from other sources (e.g., meta-analyses) or enhancing EHR data with information from research studies (clinical and biomarker data) may enhance our abilities to improve the performance of clinical prediction models.
Collapse
Affiliation(s)
- Dominic Oliver
- Department of Psychiatry, University of Oxford, Oxford, United Kingdom; NIHR Oxford Health Biomedical Research Centre, Oxford, United Kingdom; OPEN Early Detection Service, Oxford Health NHS Foundation Trust, Oxford, United Kingdom; Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
| | - Maite Arribas
- Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
| | - Benjamin I Perry
- Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom
| | - Daniel Whiting
- Institute of Mental Health, University of Nottingham, Nottingham, United Kingdom
| | - Graham Blackman
- Department of Psychiatry, University of Oxford, Oxford, United Kingdom; NIHR Oxford Health Biomedical Research Centre, Oxford, United Kingdom
| | - Kamil Krakowski
- Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom; Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy
| | - Aida Seyedsalehi
- Department of Psychiatry, University of Oxford, Oxford, United Kingdom
| | - Emanuele F Osimo
- Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom; Imperial College London Institute of Clinical Sciences and UK Research and Innovation MRC London Institute of Medical Sciences, Hammersmith Hospital Campus, London, United Kingdom; South London and the Maudsley National Health Service Foundation Trust, London, United Kingdom
| | - Siân Lowri Griffiths
- Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom
| | - Daniel Stahl
- Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom
| | - Andrea Cipriani
- NIHR Oxford Health Biomedical Research Centre, Oxford, United Kingdom; Department of Psychiatry, University of Oxford, Oxford, United Kingdom; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, United Kingdom
| | - Seena Fazel
- Department of Psychiatry, University of Oxford, Oxford, United Kingdom; NIHR Oxford Health Biomedical Research Centre, Oxford, United Kingdom
| | - Paolo Fusar-Poli
- Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom; Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy; South London and the Maudsley National Health Service Foundation Trust, London, United Kingdom; Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University Munich, Munich, Germany
| | - Philip McGuire
- Department of Psychiatry, University of Oxford, Oxford, United Kingdom; NIHR Oxford Health Biomedical Research Centre, Oxford, United Kingdom; OPEN Early Detection Service, Oxford Health NHS Foundation Trust, Oxford, United Kingdom
| |
Collapse
|
14
|
Benrimoh D, Dlugunovych V, Wright AC, Phalen P, Funaro MC, Ferrara M, Powers AR, Woods SW, Guloksuz S, Yung AR, Srihari V, Shah J. On the proportion of patients who experience a prodrome prior to psychosis onset: A systematic review and meta-analysis. Mol Psychiatry 2024:10.1038/s41380-024-02415-w. [PMID: 38302562 DOI: 10.1038/s41380-024-02415-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/11/2023] [Revised: 12/20/2023] [Accepted: 01/04/2024] [Indexed: 02/03/2024]
Abstract
BACKGROUND Preventing or delaying the onset of psychosis requires identification of those at risk for developing psychosis. For predictive purposes, the prodrome - a constellation of symptoms which may occur before the onset of psychosis - has been increasingly recognized as having utility. However, it is unclear what proportion of patients experience a prodrome or how this varies based on the multiple definitions used. METHODS We conducted a systematic review and meta-analysis of studies of patients with psychosis with the objective of determining the proportion of patients who experienced a prodrome prior to psychosis onset. Inclusion criteria included a consistent prodrome definition and reporting the proportion of patients who experienced a prodrome. We excluded studies of only patients with a prodrome or solely substance-induced psychosis, qualitative studies without prevalence data, conference abstracts, and case reports/case series. We searched Ovid MEDLINE, Embase (Ovid), APA PsycInfo (Ovid), Web of Science Core Collection (Clarivate), Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, APA PsycBooks (Ovid), ProQuest Dissertation & Thesis, on March 3, 2021. Studies were assessed for quality using the Critical Appraisal Checklist for Prevalence Studies. Narrative synthesis and proportion meta-analysis were used to estimate prodrome prevalence. I2 and predictive interval were used to assess heterogeneity. Subgroup analyses were used to probe sources of heterogeneity. (PROSPERO ID: CRD42021239797). RESULTS Seventy-one articles were included, representing 13,774 patients. Studies varied significantly in terms of methodology and prodrome definition used. The random effects proportion meta-analysis estimate for prodrome prevalence was 78.3% (95% CI = 72.8-83.2); heterogeneity was high (I2 97.98% [95% CI = 97.71-98.22]); and the prediction interval was wide (95% PI = 0.411-0.936). There were no meaningful differences in prevalence between grouped prodrome definitions, and subgroup analyses failed to reveal a consistent source of heterogeneity. CONCLUSIONS This is the first meta-analysis on the prevalence of a prodrome prior to the onset of first episode psychosis. The majority of patients (78.3%) were found to have experienced a prodrome prior to psychosis onset. However, findings are highly heterogenous across study and no definitive source of heterogeneity was found despite extensive subgroup analyses. As most studies were retrospective in nature, recall bias likely affects these results. While the large majority of patients with psychosis experience a prodrome in some form, it is unclear if the remainder of patients experience no prodrome, or if ascertainment methods employed in the studies were not sensitive to their experiences. Given widespread investment in indicated prevention of psychosis through prospective identification and intervention during the prodrome, a resolution of this question as well as a consensus definition of the prodrome is much needed in order to effectively direct and organize services, and may be accomplished through novel, densely sampled and phenotyped prospective cohort studies that aim for representative sampling across multiple settings.
Collapse
Affiliation(s)
- David Benrimoh
- PEPP-Montréal, Department of Psychiatry and Douglas Research Center, McGill University, Montreal, QC, Canada.
- Department of Psychiatry, Stanford University, Stanford, CA, USA.
| | | | - Abigail C Wright
- Center of Excellence for Psychosocial and Systemic Research, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA
- Harvard Medical School, Boston, MA, USA
| | - Peter Phalen
- Division of Psychiatric Services Research, University of Maryland School of Medicine, Baltimore, MD, USA
| | - Melissa C Funaro
- Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, CT, USA
| | - Maria Ferrara
- Institute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy
- Specialized Treatment Early in Psychosis Program (STEP), Yale School of Medicine, New Haven, CT, USA
| | - Albert R Powers
- Yale University School of Medicine and the Connecticut Mental Health Center, New Haven, CT, USA
| | - Scott W Woods
- Yale University School of Medicine and the Connecticut Mental Health Center, New Haven, CT, USA
| | - Sinan Guloksuz
- Specialized Treatment Early in Psychosis Program (STEP), Yale School of Medicine, New Haven, CT, USA
- Department of Psychiatry and Neuropsychology Maastricht University Medical Center, Maastricht, Netherlands
| | - Alison R Yung
- Institute of Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Melbourne, Australia
| | - Vinod Srihari
- Yale University School of Medicine and the Connecticut Mental Health Center, New Haven, CT, USA
| | - Jai Shah
- PEPP-Montréal, Department of Psychiatry and Douglas Research Center, McGill University, Montreal, QC, Canada
| |
Collapse
|
15
|
Shah JL. Revitalizing the role of social determinants in mental health. World Psychiatry 2024; 23:93-94. [PMID: 38214622 PMCID: PMC10785966 DOI: 10.1002/wps.21163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/13/2024] Open
Affiliation(s)
- Jai L Shah
- Department of Psychiatry, Douglas Research Centre and McGill University, Montréal, QC, Canada
| |
Collapse
|
16
|
McIlwaine SV, Mughal S, Ferrari M, Rosengard R, Malla A, Iyer S, Lepage M, Joober R, Shah JL. Pre-onset subthreshold psychotic symptoms are associated with differential treatment delays before a first episode of psychosis: Initial evidence and implications. Schizophr Res 2024; 264:549-556. [PMID: 38335764 DOI: 10.1016/j.schres.2024.01.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Revised: 12/08/2023] [Accepted: 01/30/2024] [Indexed: 02/12/2024]
Abstract
BACKGROUND Help-seeking and treatment delays are increasingly critical areas of study in mental health services. The duration of untreated psychosis (DUP), or the time between illness onset and initiation of treatment, is a predictor of symptom remission and functioning for a first episode of psychosis (FEP). The World Health Organization recommends that specialized treatment for psychosis be initiated within the first three months of FEP onset. As a result, research has focused on factors that are associated with threshold-level DUP, while the experience of subthreshold psychotic symptoms (STPS) prior to a FEP may also complicate and present barriers to accessing care for young people. We therefore examine the possibility that STPS can impact DUP and its components. METHOD Using a follow-back cross-sectional design, we sought to describe duration of untreated illness, length of prodrome, DUP, help-seeking delay, referral delay, and number of help-seeking contacts among FEP patients who did and did not have STPS prior to psychosis onset. RESULTS We found that patients who experienced STPS had a longer median duration of untreated illness, prodrome length, DUP, and help-seeking delay compared to patients who did not have such symptoms. Referral delay did not differ substantially between the two groups. Importantly, treatment delays were extremely lengthy for many participants. CONCLUSIONS Pre-onset STPS are associated with help-seeking delays along the pathway to care even during a FEP. Examining early signs and symptoms may help to improve and tailor interventions aimed at reducing treatment delays and ultimately providing timely care when the need arises.
Collapse
Affiliation(s)
- S V McIlwaine
- Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Canada; Prevention and Early Intervention for Psychosis Programme (PEPP-Montreal), Douglas Mental Health University Institute, Canada.
| | - S Mughal
- Prevention and Early Intervention for Psychosis Programme (PEPP-Montreal), Douglas Mental Health University Institute, Canada; Department of Psychiatry, McGill University, Canada
| | - M Ferrari
- Prevention and Early Intervention for Psychosis Programme (PEPP-Montreal), Douglas Mental Health University Institute, Canada; Department of Psychiatry, McGill University, Canada
| | - R Rosengard
- Prevention and Early Intervention for Psychosis Programme (PEPP-Montreal), Douglas Mental Health University Institute, Canada; Department of Psychiatry, McGill University, Canada
| | - A Malla
- Prevention and Early Intervention for Psychosis Programme (PEPP-Montreal), Douglas Mental Health University Institute, Canada; Department of Psychiatry, McGill University, Canada
| | - S Iyer
- Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Canada; Prevention and Early Intervention for Psychosis Programme (PEPP-Montreal), Douglas Mental Health University Institute, Canada; Department of Psychiatry, McGill University, Canada
| | - M Lepage
- Prevention and Early Intervention for Psychosis Programme (PEPP-Montreal), Douglas Mental Health University Institute, Canada; Department of Psychiatry, McGill University, Canada; Department of Psychology, McGill University, Canada
| | - R Joober
- Prevention and Early Intervention for Psychosis Programme (PEPP-Montreal), Douglas Mental Health University Institute, Canada; Department of Psychiatry, McGill University, Canada
| | - J L Shah
- Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Canada; Prevention and Early Intervention for Psychosis Programme (PEPP-Montreal), Douglas Mental Health University Institute, Canada; Department of Psychiatry, McGill University, Canada
| |
Collapse
|
17
|
Jalali S, Liu L, Wang J, Kennedy SH, MacQueen G, Lebel C, Goldstein BL, Bray S, Addington J. Factors Associated with Transition to Serious Mental Illness. CANADIAN JOURNAL OF PSYCHIATRY. REVUE CANADIENNE DE PSYCHIATRIE 2024; 69:79-88. [PMID: 37606525 PMCID: PMC10789229 DOI: 10.1177/07067437231195959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 08/23/2023]
Abstract
OBJECTIVE There is increasing interest in early intervention and detection strategies for youth at-risk of developing a serious mental illness (SMI). Little is known about early factors that may be related to the later development of a SMI; thus, the aim of this study was to determine what clinical factors might relate to the development of in this study psychosis, bipolar disorder and severe or recurrent major depression in at-risk youth. METHOD The sample consisted of 162 youth aged 12-26 years at different stages of risk. Thirty-one participants developed a SMI during the study. Those who made a transition were compared on a range of baseline clinical and functional measures with those who did not make the transition. A Cox regression model was used to assess the association between measures and later development of a SMI. RESULTS Female sex, attenuated psychotic symptoms as assessed with the Scale of Psychosis-Risk Symptoms (SOPS) and ratings on the K-10 Distress Scale, were found to be significantly associated with the later transition to mental illness. Females were 2.77 times more likely to transition compared to males. For the SOPS and K-10 scales, there is a 14% increase in the transition rate relative to a one-scale increase in SOPS and a 7% increase in the transition rate relative to a one-point increase in the K-10. CONCLUSIONS Results from these longitudinal data provide further insight into the specific clinical measures that may be pertinent in early detection of mental illnesses.
Collapse
Affiliation(s)
- Sara Jalali
- Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
| | - Lu Liu
- Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
| | - JianLi Wang
- Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
- Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
| | - Sidney H. Kennedy
- Department of Psychiatry, University Health Network, Toronto, Ontario, Canada
- Department of Psychiatry, St. Michael's Hospital, Toronto, Ontario, Canada
- Arthur Sommer Rotenberg Chair in Suicide and Depression Studies, St. Michael's Hospital, Toronto, Ontario, Canada
- Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada
- Krembil Research Institute, University Health Network, Toronto, Ontario, Canada
| | - Glenda MacQueen
- Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
| | - Catherine Lebel
- Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
- Department of Radiology, University of Calgary, Calgary, Alberta, Canada
- Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada
- Child & Adolescent Imaging Research (CAIR) Program, Calgary, Alberta, Canada
| | - Benjamin l. Goldstein
- Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- Departments of Psychiatry and Pharmacology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Signe Bray
- Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
- Department of Radiology, University of Calgary, Calgary, Alberta, Canada
- Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada
- Child & Adolescent Imaging Research (CAIR) Program, Calgary, Alberta, Canada
| | - Jean Addington
- Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
| |
Collapse
|
18
|
Wittevrongel E, van Winkel R, Jackers M, Colman L, Versyck M, Camp E, Everaert G, Vrijens M, Baeyens D, Danckaerts M. How to make mental health services more youth-friendly? A Delphi study involving young adults, parents and professionals. Health Expect 2023; 26:2532-2548. [PMID: 37608557 PMCID: PMC10632649 DOI: 10.1111/hex.13832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2023] [Revised: 07/15/2023] [Accepted: 07/20/2023] [Indexed: 08/24/2023] Open
Abstract
INTRODUCTION Although youth-friendly service characteristics have been previously identified, consensus among a representative group of stakeholders about which of these characteristics are truly relevant to the youth-friendliness of services is currently lacking. In our study, young adults, parents and professionals were consulted on this topic to reveal existing (dis)agreement. In addition, (dis)agreement on feasibility for implementation in clinical practice was also assessed. METHODS A mixed-method Delphi approach was used with three online questionnaire rounds and a physical meeting. Young adults (18-26 years) and parents were part of a public panel and professionals were allocated to the professional panel. In the rounds, participants were asked to rate the importance and feasibility of each item. Subsequently, the percentage agreement (% of participants giving a score of 7 or above on a 9-point Likert scale) within and across panels was calculated. Consensus was assumed to have been reached when at least 70% agreement was achieved. A thematic analysis of the qualitative data, obtained in the rounds and the physical meeting, was performed to identify overarching themes and characteristics of relevance to the youth-friendliness of services. RESULTS For 65% of the items included in the Delphi questionnaire, consensus on importance was reached within both panels. Participants showed more insecurity about the feasibility of these items, however. Our thematic analysis revealed reasons for disagreement between and within the panels. CONCLUSIONS Our study revealed substantial between- and within-panel agreement on youth-friendly service characteristics. We recommend that the items for which consensus was reached should be used as a checklist in terms of youth mental health service development, design and delivery. The characteristics for which there was disagreement between and within the panels should inspire an ongoing trialogue between young adults, parents and professionals both on the individual level and the service level. PATIENT OR PUBLIC CONTRIBUTION In this study, (parents of) young adults with lived experience were included as experts, including one of the coauthors. This coauthor contributed to the manuscript by having a final say about the included quotes.
Collapse
Affiliation(s)
- Eline Wittevrongel
- Department of Neurosciences, Research Group Psychiatry, Center for Clinical PsychiatryKU LeuvenLeuvenBelgium
- University Psychiatric Center (UPC) KU LeuvenLeuvenBelgium
| | - Ruud van Winkel
- Department of Neurosciences, Research Group Psychiatry, Center for Clinical PsychiatryKU LeuvenLeuvenBelgium
- University Psychiatric Center (UPC) KU LeuvenLeuvenBelgium
| | - Maarten Jackers
- Department of Neurosciences, Research Group Psychiatry, Center for Clinical PsychiatryKU LeuvenLeuvenBelgium
| | | | - Melina Versyck
- Faculty of MedicineKU LeuvenLeuvenBelgium
- mArquee Multiversum Psychiatric HospitalAntwerpenBelgium
| | - Eline Camp
- Faculty of MedicineKU LeuvenLeuvenBelgium
| | - Geert Everaert
- Neuro‐Psychiatric Clinic Saint Joseph V.Z.W.PittemBelgium
| | - May Vrijens
- Asster Psychiatric HospitalSint‐TruidenBelgium
| | - Dieter Baeyens
- Faculty of Psychology and Educational Sciences, Parenting and Special EducationKU LeuvenLeuvenBelgium
| | - Marina Danckaerts
- University Psychiatric Center (UPC) KU LeuvenLeuvenBelgium
- Department of Neurosciences, Research Group Psychiatry, Center for Developmental PsychiatryKU LeuvenLeuvenBelgium
| |
Collapse
|
19
|
Dumble J, Sadler P, Cottrell T, Planinic A, Perin S, Harrison C, Moss F, Aradhye S, Chong TW. Too late for early intervention? The Healthy Ageing Service's mental health response. Australas Psychiatry 2023; 31:830-834. [PMID: 37915128 DOI: 10.1177/10398562231211669] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/03/2023]
Abstract
OBJECTIVES This paper describes the rationale for and development of an innovative mental health service for people aged over 65 years living in Northern and Eastern Melbourne, Victoria, Australia. CONCLUSION The Healthy Ageing Service (HAS) was established in July 2020 to provide care for people aged over 65 years experiencing mild-to-moderate mental health concerns. It embraces a prevention and early intervention model of care. It provides primary consultation and brief intervention, secondary consultation, and capacity building to the primary healthcare sector. This innovative service is a Commonwealth-funded partnership between two tertiary mental health service providers that incorporates the recommendations from two major Royal Commissions. It demonstrates a service that acts as a bridge between primary and specialist mental health care, thereby extending mental health services to target the 'missing middle' and is potentially a model for mental health service provision throughout Victoria and Australia.
Collapse
Affiliation(s)
- Jessica Dumble
- St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia; Eastern Health, Box Hill, VIC, Australia
| | | | - Tanya Cottrell
- St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia; Academic Unit for Psychiatry of Old Age, Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia
| | | | - Stephanie Perin
- St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia; Academic Unit for Psychiatry of Old Age, Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia
| | - Chris Harrison
- St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia
| | - Francine Moss
- St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia; Academic Unit for Psychiatry of Old Age, Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia
| | | | - Terence Wh Chong
- St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia; Academic Unit for Psychiatry of Old Age, Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia; Royal Melbourne Hospital, Parkville, VIC, Australia
| |
Collapse
|
20
|
Marconi E, Monti L, Fredda G, Kotzalidis GD, Janiri D, Zani V, Vitaletti D, Simone MV, Piciollo S, Moriconi F, Di Pietro E, Popolo R, Dimaggio G, Veredice C, Sani G, Chieffo DPR. Outpatient care for adolescents' and young adults' mental health: promoting self- and others' understanding through a metacognitive interpersonal therapy-informed psychological intervention. Front Psychiatry 2023; 14:1221158. [PMID: 38025443 PMCID: PMC10651761 DOI: 10.3389/fpsyt.2023.1221158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/11/2023] [Accepted: 10/02/2023] [Indexed: 12/01/2023] Open
Abstract
Introduction Psychological distress may result in impairment and difficulty understanding oneself and others. Thus, addressing metacognitive issues in psychotherapy may improve psychopathology in adolescents and young adults (AYAs). We aimed to compare metacognitive interpersonal therapy (MIT)-informed psychotherapy with other treatment-as-usual (TAU) therapies. Methods We administered the Global Assessment of Functioning (GAF) scale, the Clinical Global Impressions-Severity (CGI-S) scale, and the Brief Psychiatric Rating Scale (BPRS) at baseline (BL) and at treatment termination (the endpoint was at 6 months and any last results obtained before that term were carried forward in analyzes). Patients received concomitant psychiatric and psychological treatment. Results Sixty AYAs were involved in the study. There was a significant reduction in symptomatology after the intervention. Twelve patients (17%) dropped out; treatment adherence was 83%. In the MIT group, 2 patients dropped out (11%), and in the TAU group, 9 patients dropped out (19%). All scales showed a significant reduction in symptoms between baseline (BL) and the 6-month endpoint: GAF (χ2 = 6.61, p < 0.001), BPRS (χ2 = 6.77, p < 0.001), and CGI (χ2 = 7.20, p < 0.001). There was a greater efficacy for the MIT group in terms of symptom reduction on the BPRS (t = 2.31; p < 0.05). Conclusion The study confirmed the efficacy of early and integrated care in adolescence and suggested greater symptom reduction for a psychotherapeutic intervention focused on stimulating mentalization skills. The study indicates the usefulness of this type of approach in the treatment of adolescent psychopathology. Due to the small sample size, the results need replication.
Collapse
Affiliation(s)
- Elisa Marconi
- Clinical Psychology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
| | - Laura Monti
- Clinical Psychology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
| | - Giulia Fredda
- Clinical Psychology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
| | - Georgios D. Kotzalidis
- Department of Psychiatry, Department of Neuroscience, Head, Neck and Thorax, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
- NESMOS Department (Neurosciences, Mental Health, and Sensory Organs), University of Rome “La Sapienza”, Rome, Italy
| | - Delfina Janiri
- Department of Psychiatry, Department of Neuroscience, Head, Neck and Thorax, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
| | - Valentina Zani
- Catholic University of the Sacred Heart–Rome, Rome, Italy
| | | | | | | | - Federica Moriconi
- Clinical Psychology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
| | | | - Raffaele Popolo
- Center for Metacognitive Interpersonal Therapy, Rome, Italy
- Department of Mental Health, Rome, Italy
| | | | - Chiara Veredice
- Pediatric Neuropsychiatry Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
| | - Gabriele Sani
- Department of Psychiatry, Department of Neuroscience, Head, Neck and Thorax, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
- Institute of Psychiatry, Department of Neuroscience, Catholic University of the Sacred Heart–Rome, Rome, Italy
| | - Daniela Pia Rosaria Chieffo
- Clinical Psychology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
- Department of Life Sciences and Public Health Department, Catholic University of Sacred Heart, Rome, Italy
| |
Collapse
|
21
|
Paquin V, Malla AK, Iyer SN, Lepage M, Joober R, Shah JL. Combinations and Temporal Associations Among Precursor Symptoms Before a First Episode of Psychosis. Schizophr Bull 2023:sbad152. [PMID: 37861419 DOI: 10.1093/schbul/sbad152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2023]
Abstract
BACKGROUND AND HYPOTHESIS Symptoms that precede a first episode of psychosis (FEP) can ideally be targeted by early intervention services with the aim of preventing or delaying psychosis onset. However, these precursor symptoms emerge in combinations and sequences that do not rest fully within traditional diagnostic categories. To advance our understanding of illness trajectories preceding FEP, we aimed to investigate combinations and temporal associations among precursor symptoms. STUDY DESIGN Participants were from PEPP-Montréal, a catchment-based early intervention program for FEP. Through semistructured interviews, collateral from relatives, and a review of health and social records, we retrospectively measured the presence or absence of 29 precursor symptoms, including 9 subthreshold psychotic and 20 nonpsychotic symptoms. Sequences of symptoms were derived from the timing of the first precursor symptom relative to the onset of FEP. STUDY RESULTS The sample included 390 participants (68% men; age range: 14-35 years). Combinations of precursor symptoms most frequently featured depression, anxiety, and substance use. Of 256 possible pairs of initial and subsequent precursor symptoms, many had asymmetrical associations: eg, when the first symptom was suspiciousness, the incidence rate ratio (IRR) of subsequent anxiety was 3.40 (95% confidence interval [CI]: 1.79, 6.46), but when the first symptom was anxiety, the IRR of subsequent suspiciousness was 1.15 (95% CI: 0.77, 1.73). CONCLUSIONS A detailed examination of precursor symptoms reveals diverse clinical profiles that cut across diagnostic categories and evolve longitudinally prior to FEP. Their identification may contribute to risk assessments and provide insights into the mechanisms of illness progression.
Collapse
Affiliation(s)
- Vincent Paquin
- Prevention and Early Intervention Program for Psychosis (PEPP-Montreal), Douglas Mental Health University Institute, Montreal, QC, Canada
- Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Ashok K Malla
- Prevention and Early Intervention Program for Psychosis (PEPP-Montreal), Douglas Mental Health University Institute, Montreal, QC, Canada
- Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Srividya N Iyer
- Prevention and Early Intervention Program for Psychosis (PEPP-Montreal), Douglas Mental Health University Institute, Montreal, QC, Canada
- Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Martin Lepage
- Prevention and Early Intervention Program for Psychosis (PEPP-Montreal), Douglas Mental Health University Institute, Montreal, QC, Canada
- Department of Psychiatry, McGill University, Montreal, QC, Canada
- Integrated Program in Neuroscience, McGill University, Montreal, QC, Canada
| | - Ridha Joober
- Prevention and Early Intervention Program for Psychosis (PEPP-Montreal), Douglas Mental Health University Institute, Montreal, QC, Canada
- Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Jai L Shah
- Prevention and Early Intervention Program for Psychosis (PEPP-Montreal), Douglas Mental Health University Institute, Montreal, QC, Canada
- Department of Psychiatry, McGill University, Montreal, QC, Canada
- Integrated Program in Neuroscience, McGill University, Montreal, QC, Canada
| |
Collapse
|
22
|
Capon W, Hickie IB, Fetanat M, Varidel M, LaMonica HM, Prodan A, Piper S, Davenport TA, Mughal S, Shah JL, Scott EM, Iorfino F. A multidimensional approach for differentiating the clinical needs of young people presenting for primary mental health care. Compr Psychiatry 2023; 126:152404. [PMID: 37524044 DOI: 10.1016/j.comppsych.2023.152404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/14/2023] [Revised: 07/18/2023] [Accepted: 07/20/2023] [Indexed: 08/02/2023] Open
Abstract
OBJECTIVES There is an ongoing necessity to match clinical interventions with the multidimensional needs of young people. A key step toward better service planning and the design of optimal models of care is to use multidimensional assessment to understand the clinical needs of those presenting to primary mental health care. METHODS 1284 people aged 12-25 years presenting to primary youth mental health services completed an online assessment at service entry. Latent class analysis was conducted for seven scales assessing anxiety, depression, psychosis, mania, functioning (indexed by Work and Social Adjustment Scale), and suicidality. RESULTS A three-class solution was identified as the optimal solution. Class 1 (n = 305, 23.75%), an early illness stage group, had low and mixed symptomatology with limited functional impairment, class 2 (n = 353, 27.49%) was made up of older persons with established depression and functional impairment, and class 3 (n = 626, 48.75%) had very high and complex needs, with functional impairment, suicidality, and at-risk mental states (psychosis or mania). Additional differentiating characteristics included psychological distress, circadian disturbances, social support, mental health history, eating disorder behaviours, and symptoms of post-traumatic stress disorder. CONCLUSIONS A large proportion of help-seeking young people present with symptoms and functional impairment that may exceed the levels of care available from basic primary care or brief intervention services. These subgroups highlight the importance of multidimensional assessments to determine appropriate service pathways and care options.
Collapse
Affiliation(s)
- William Capon
- Brain and Mind Centre, The University of Sydney, Australia.
| | - Ian B Hickie
- Brain and Mind Centre, The University of Sydney, Australia.
| | - Masoud Fetanat
- Brain and Mind Centre, The University of Sydney, Australia.
| | - Mathew Varidel
- Brain and Mind Centre, The University of Sydney, Australia.
| | | | - Ante Prodan
- Brain and Mind Centre, The University of Sydney, Australia; Translational Health Research Institute, Western Sydney University, Australia; School of Computer, Data and Mathematical Sciences, Western Sydney University, Australia.
| | - Sarah Piper
- Brain and Mind Centre, The University of Sydney, Australia.
| | | | - Sarah Mughal
- McGill University, Department of Psychiatry, Montreal, Canada.
| | - Jai L Shah
- McGill University, Department of Psychiatry, Montreal, Canada.
| | | | - Frank Iorfino
- Brain and Mind Centre, The University of Sydney, Australia.
| |
Collapse
|
23
|
Uhlhaas PJ, Davey CG, Mehta UM, Shah J, Torous J, Allen NB, Avenevoli S, Bella-Awusah T, Chanen A, Chen EYH, Correll CU, Do KQ, Fisher HL, Frangou S, Hickie IB, Keshavan MS, Konrad K, Lee FS, Liu CH, Luna B, McGorry PD, Meyer-Lindenberg A, Nordentoft M, Öngür D, Patton GC, Paus T, Reininghaus U, Sawa A, Schoenbaum M, Schumann G, Srihari VH, Susser E, Verma SK, Woo TW, Yang LH, Yung AR, Wood SJ. Towards a youth mental health paradigm: a perspective and roadmap. Mol Psychiatry 2023; 28:3171-3181. [PMID: 37580524 PMCID: PMC10618105 DOI: 10.1038/s41380-023-02202-z] [Citation(s) in RCA: 26] [Impact Index Per Article: 26.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Revised: 07/04/2023] [Accepted: 07/21/2023] [Indexed: 08/16/2023]
Abstract
Most mental disorders have a typical onset between 12 and 25 years of age, highlighting the importance of this period for the pathogenesis, diagnosis, and treatment of mental ill-health. This perspective addresses interactions between risk and protective factors and brain development as key pillars accounting for the emergence of psychopathology in youth. Moreover, we propose that novel approaches towards early diagnosis and interventions are required that reflect the evolution of emerging psychopathology, the importance of novel service models, and knowledge exchange between science and practitioners. Taken together, we propose a transformative early intervention paradigm for research and clinical care that could significantly enhance mental health in young people and initiate a shift towards the prevention of severe mental disorders.
Collapse
Affiliation(s)
- Peter J Uhlhaas
- Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, UK.
- Department of Child and Adolescent Psychiatry, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
| | - Christopher G Davey
- Department of Psychiatry, The University of Melbourne, Carlton, VIC, Australia
| | - Urvakhsh Meherwan Mehta
- Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India
| | - Jai Shah
- Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - John Torous
- Division of Digital Psychiatry and Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
| | | | - Shelli Avenevoli
- Office of the Director, National Institute of Mental Health, Bethesda, MD, USA
| | - Tolulope Bella-Awusah
- Department of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria
| | - Andrew Chanen
- Orygen: National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia
- Centre for Youth Mental Health, University of Melbourne, Parkville, VIC, Australia
| | - Eric Y H Chen
- Department of Psychiatry, University of Hong Kong, Hong Kong, China
| | - Christoph U Correll
- Department of Child and Adolescent Psychiatry, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- Departments of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hostra/Northwell, Hempstead, NY, USA
- Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA
| | - Kim Q Do
- Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland
| | - Helen L Fisher
- Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- ESRC Centre for Society and Mental Health, King's College London, London, UK
| | - Sophia Frangou
- Department of Psychiatry, The University of British Columbia, Vancouver, BC, Canada
| | - Ian B Hickie
- Brain and Mind Centre, University of Sydney, Camperdown, NSW, Australia
| | - Matcheri S Keshavan
- Department of Psychiatry, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
| | - Kerstin Konrad
- Child Neuropsychology Section, Department of Child and Adolescent Psychiatry, RWTH, Aachen, Germany
- JARA-Brain Institute II, Molecular Neuroscience and Neuroimaging, Research Center Jülich, Jülich, Germany
| | - Francis S Lee
- Department of Psychiatry, Weill Cornell Cornell Medicall College, New York, NY, USA
| | - Cindy H Liu
- Departments of Pediatrics and Psychiatry, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, USA
| | - Beatriz Luna
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
| | - Patrick D McGorry
- Orygen: National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia
- Centre for Youth Mental Health, University of Melbourne, Parkville, VIC, Australia
| | - Andreas Meyer-Lindenberg
- Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany
| | - Merete Nordentoft
- CORE-Copenhagen Research Centre for Mental Health, Mental Health Center Copenhagen, University of Copenhagen, Faculty of Health and Medical Sciences, Department of Clinical Medicine, Hellerup, Denmark
| | - Dost Öngür
- McLean Hospital/Harvard Medical School, Belmont, MA, USA
| | - George C Patton
- Centre for Adolescent Health, Murdoch Children's Research Institute, University of Melbourne, Parkville, VIC, Australia
| | - Tomáš Paus
- Departments of Psychiatry and Neuroscience, Faculty of Medicine and Centre Hospitalier Universitaire Sainte Justine, University of Montreal, Montreal, QC, Canada
- Department of Psychology and Psychiatry, University of Toronto, Toronto, ON, Canada
| | - Ulrich Reininghaus
- Department of Public Mental Health, Central Institute of Mental Health, Medical Faculty Mannheim, Mannheim, Germany
- Centre for Epidemiology and Public Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Akira Sawa
- The John Hopkins Schizophrenia Center, Johns Hopkins University, Baltimore, MD, USA
| | - Michael Schoenbaum
- Division of Service and Intervention Research, National Institute of Mental Health, Bethesda, MD, USA
| | - Gunter Schumann
- Centre for Population Neuroscience and Stratified Medicine, ISTBI, Fudan University, Shanghai, China
- Department of Psychiatry and Neuroscience, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Vinod H Srihari
- Department of Psychiatry, Yale University, New Haven, CT, USA
- Program for Specialized Treatment Early in Psychosis (STEP), New Haven, VIC, USA
| | - Ezra Susser
- Departments of Epidemiology and Psychiatry, Columbia University, New York, NY, USA
- New York State Psychiatric Institute, New York, NY, USA
| | - Swapna K Verma
- Department of Psychosis, Institute of Mental Health, Buangkok, Singapore
- Duke-NUS Medical School, Singapore, Singapore
| | - T Wilson Woo
- Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, USA
- Laboratory for Cellular Neuropathology, McLean Hospital, Belmont, MA, USA
- Department of Psychiatry, Harvard Medical School, Boston, MA, USA
| | - Lawrence H Yang
- Department of Social and Behavioral Sciences, New York University, New York, NY, USA
- Department of Epidemiology, Columbia University, New York, NY, USA
| | - Alison R Yung
- School of Medicine, Faculty of Health, Deakin University, Melbourne, VIC, Australia
- Department of Psychology and Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
| | - Stephen J Wood
- Orygen: National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia
- Centre for Youth Mental Health, University of Melbourne, Parkville, VIC, Australia
| |
Collapse
|
24
|
Dangerfield M, Brotnow Decker L. Mentalization based treatment of youth on the psychotic spectrum: clinical profiles and outcomes for youth in the ECID. Front Psychiatry 2023; 14:1206511. [PMID: 37469356 PMCID: PMC10352583 DOI: 10.3389/fpsyt.2023.1206511] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/15/2023] [Accepted: 06/20/2023] [Indexed: 07/21/2023] Open
Abstract
Introduction Early intervention may significantly improve the prognosis associated with psychotic disorders in adulthood. Methods The present study examined the acceptability and effectiveness of a standalone intensive, in-home, mentalization-based treatment (MBT) for extremely high-risk, non-help-seeking youth on the psychotic spectrum [Equipo Clínico de Intervención a Domicilio (ECID), Home Intervention Clinical Team]. Results Despite previously being unable to participate in treatment, more than 90% of youth engaged and those on the psychotic spectrum demonstrated slightly higher engagement than the general high-risk group (95% and 85%, respectively, X1 = 4.218, p = 0.049). Generalized estimating equation (GEE) models revealed no main group effect on the likelihood of reengaging with school over the first 12 months of treatment (X1 = 1.015, p = 0.314) when controlling for the duration of school absenteeism at intake. Overall, the percentage of school engagement rose from 12 to 55 over this period, more than 40% of the total sample experienced clinically reliable change and an additional 50% appeared clinically stable. No statistically significant difference was observed between the groups in the average change in HoNOSCA total severity score (X1 = 0.249, p = 0.618) or the distribution of youth into categories of clinical change during the first year of treatment (X1 = 0.068, p = 0.795). Discussion The present findings suggest that a mentalization based intervention may be able to engage extremely high-risk youth in treatment and have clinically meaningful impact on symptom severity and functioning after 12 months.
Collapse
Affiliation(s)
- Mark Dangerfield
- Vidal and Barraquer University Institute of Mental Health, Ramon Llull University, Barcelona, Spain
| | | |
Collapse
|
25
|
Belvederi Murri M, Ferrara M, Imbesi M, Leuci E, Marchi M, Musella V, Natali A, Neri A, Ragni S, Saponaro A, Tarricone I, Tullini A, Starace F. A public early intervention approach to first-episode psychosis: Treated incidence over 7 years in the Emilia-Romagna region. Early Interv Psychiatry 2023. [PMID: 37221039 DOI: 10.1111/eip.13437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/18/2022] [Revised: 03/28/2023] [Accepted: 05/05/2023] [Indexed: 05/25/2023]
Abstract
AIM To estimate the treated incidence of individuals with first-episode psychosis (FEP) who contacted the Emilia-Romagna public mental healthcare system (Italy); to examine the variability of incidence and user characteristics across centres and years. METHODS We computed the raw treated incidence in 2013-2019, based on FEP users aged 18-35, seen within or outside the regional program for FEP. We modelled FEP incidence across 10 catchment areas and 7 years using Bayesian Poisson and Negative Binomial Generalized Linear Models of varying complexity. We explored associations between user characteristics, study centre and year comparing variables and socioclinical clusters of subjects. RESULTS Thousand three hundred and eighteen individuals were treated for FEP (raw incidence: 25.3 / 100.000 inhabitant year, IQR: 15.3). A Negative Binomial location-scale model with area, population density and year as predictors found that incidence and its variability changed across centres (Bologna: 36.55; 95% CrI: 30.39-43.86; Imola: 3.07; 95% CrI: 1.61-4.99) but did not follow linear temporal trends or density. Centers were associated with different user age, gender, migrant status, occupation, living conditions and cluster distribution. Year was associated negatively with HoNOS score (R = -0.09, p < .001), duration of untreated psychosis (R = -0.12, p < .001) and referral type. CONCLUSIONS The Emilia-Romagna region presents a relatively high but variable incidence of FEP across areas, but not in time. More granular information on social, ethnic and cultural factors may increase the level of explanation and prediction of FEP incidence and characteristics, shedding light on social and healthcare factors influencing FEP.
Collapse
Affiliation(s)
- Martino Belvederi Murri
- Institute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy
| | - Maria Ferrara
- Institute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy
- Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA
| | - Massimiliano Imbesi
- Department of Mental Health and Substance Abuse, AUSL Piacenza, Piacenza, Italy
| | - Emanuela Leuci
- Department of Mental Health and Pathological Addiction, AUSL Parma, Parma, Italy
| | - Mattia Marchi
- Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Vincenzo Musella
- Dipartimento di Salute Mentale e Dipendenze Patologiche, AUSL, Modena, Italy
| | - Alba Natali
- Department of Mental Health and Pathological Addiction, AUSL Imola, Imola, Italy
| | - Anastasia Neri
- Department of Mental Health and Pathological Addiction, AUSL Ravenna, Ravenna, Italy
| | - Sabrina Ragni
- Department of Mental Health and Pathological Addiction, AUSL Cesena, Cesena, Italy
| | - Alessio Saponaro
- General Directorate of Health and Social Policies, Emilia-Romagna Region, Bologna, Italy
| | - Ilaria Tarricone
- Department of Medical and Surgical Sciences, Bologna Transcultural Psychosomatic Team (BoTPT), University of Bologna, Bologna, Italy
| | - Andrea Tullini
- Department of Mental Health and Pathological Addiction, AUSL Rimini, Rimini, Italy
| | - Fabrizio Starace
- Dipartimento di Salute Mentale e Dipendenze Patologiche, AUSL, Modena, Italy
| |
Collapse
|
26
|
Cohen BM, Öngür D. The need for evidence-based updating of ICD and DSM models of psychotic and mood disorders. Mol Psychiatry 2023; 28:1836-1838. [PMID: 36697753 DOI: 10.1038/s41380-023-01967-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/12/2022] [Revised: 01/09/2023] [Accepted: 01/16/2023] [Indexed: 01/26/2023]
Affiliation(s)
- Bruce M Cohen
- Robertson Steele Professor of Psychiatry, Harvard Medical School, Boston, MA, USA.
- President and Psychiatrist in Chief, Emeritus, McLean Hospital, 115 Mill St., Belmont, MA, 02478, USA.
| | - Dost Öngür
- William P. and Henry B. Test Professor of Psychiatry, Harvard Medical School, Boston, MA, USA
- Chief, Division of Psychotic Disorders, McLean Hospital, 115 Mill St., Belmont, MA, USA
| |
Collapse
|
27
|
Amerio A, Vai E, Bruno E, Costanza A, Escelsior A, Odone A, De Berardis D, Aguglia A, Serafini G, Amore M, Ghaemi SN. COVID-19 Impact on the Italian Community-based System of Mental Health Care: Reflections and Lessons Learned for the Future. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE : THE OFFICIAL SCIENTIFIC JOURNAL OF THE KOREAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY 2023; 21:2-9. [PMID: 36700307 PMCID: PMC9889896 DOI: 10.9758/cpn.2023.21.1.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 09/19/2022] [Accepted: 10/04/2022] [Indexed: 01/27/2023]
Abstract
Despite the unprecedented wave of research and publications sparked by the recent pandemic, only few studies have investigated the impact of COVID-19 on the Italian community-based system of mental health care. We aimed to summarize the available evidence from the literature also considering what we have learned from our daily clinical practice. As hospital care was restricted by COVID-19, although reducing their opening hours and activities, Community Mental Health Centers promoted continuity of care for at-risk populations, supporting them to cope with loneliness and hopelessness during quarantine and self-isolation. Ensuring continuity of care also remotely, via teleconsultation, lowered the risk of psychopathological decompensation and consequent need of hospitalization for mental health patients, with satisfaction expressed both by patients and mental health workers. Considering what we have learned from the pandemic, the organization and the activity of the Italian community-based system of mental health care would need to be implemented through 1) the promotion of a "territorial epidemiology" that makes mental health needs visible in terms of health care workers involved, 2) the increase of mental health resources in line with the other European high-income countries, 3) the formalization of structured initiatives of primary care and mental health cooperation, 4) the creation of youth mental health services following a multidimensional and multidisciplinary approach and encouraging family participation, 5) the promotion of day centers, to build competence and self-identity within a more participatory life, and programs geared to employment as valid models of recovery-oriented rehabilitation.
Collapse
Affiliation(s)
- Andrea Amerio
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, Genoa, Italy,IRCCS Ospedale Policlinico San Martino, Genoa, Italy,Address for correspondence: Andrea Amerio Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, IRCCS San Martino, L.go R. Benzi 10, 16100, Genova, Italy, E-mail: , ORCID: https://orcid.org/0000-0002-3439-340X
| | - Eleonora Vai
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, Genoa, Italy,IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - Edoardo Bruno
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, Genoa, Italy,IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - Alessandra Costanza
- Department of Psychiatry, Faculty of Medicine, University of Geneva (UNIGE), Geneva, Switzerland,Department of Psychiatry, Faculty of Biomedical Sciences, University of Italian Switzerland (USI), Lugano, Switzerland
| | - Andrea Escelsior
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, Genoa, Italy,IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - Anna Odone
- Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy
| | - Domenico De Berardis
- NHS, Department of Mental Health, Psychiatric Service for Diagnosis and Treatment, Hospital, “G. Mazzini”, ASL 4, Teramo, Italy
| | - Andrea Aguglia
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, Genoa, Italy,IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - Gianluca Serafini
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, Genoa, Italy,IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - Mario Amore
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, Genoa, Italy,IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - Seyyed Nassir Ghaemi
- Department of Psychiatry, Tufts University School of Medicine, MA, USA,Department of Psychiatry, Harvard Medical School, Boston, MA, USA
| |
Collapse
|
28
|
Cavelti M, Sharp C, Chanen AM, Kaess M. Commentary: Commentary on the Twitter comments evoked by the May 2022 debate on diagnosing personality disorders in adolescents. Child Adolesc Ment Health 2023; 28:186-191. [PMID: 36478638 DOI: 10.1111/camh.12618] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/10/2022] [Indexed: 12/12/2022]
Abstract
The debate about the value and utility of personality disorder (PD) diagnosis in adolescence published in the May 2022 issue of CAMH generated fervent Twitter discussion. This commentary addresses some points raised in the Twitter discussion that represent important social and/or cultural beliefs that are often presented in day-to-day practice but are rarely tested in the context of scientific evidence. This includes, in particular, the assertion that symptoms used to diagnose personality disorder are better described as sequelae of trauma, and the assertion that effective treatment for PD is possible without a diagnosis. The call for a fundamental transformation of mental health services that currently do not meet the needs of people with PD and for the involvement of people with lived experience as equal partner in this process is supported by evidence and might represent common ground among those clinician-scientist advocating for early intervention for PD and those expressing their concerns about this issue.
Collapse
Affiliation(s)
- Marialuisa Cavelti
- University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland
| | - Carla Sharp
- Department of Psychology, University of Houston, Houston, Texas, USA
| | - Andrew M Chanen
- Orygen, Melbourne, Victoria, Australia
- Centre for Youth Mental Health, University of Melbourne, Melbourne, Victoria, Australia
| | - Michael Kaess
- University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland
- Department of Child and Adolescent Psychiatry, Centre for Psychosocial Medicine, University of Heidelberg, Heidelberg, Germany
| |
Collapse
|
29
|
Karcher NR, Hicks R, Schiffman J, Asarnow JR, Calkins ME, Dauberman JL, Garrett CD, Koli RL, Larrauri CA, Loewy RL, McGough CA, Murphy JM, Niendam TA, Roaten K, Rodriguez J, Staglin BK, Wissow L, Woodberry KA, Young JF, Gur RE, Bearden CE, Barch DM. Youth Mental Health Screening and Linkage to Care. Psychiatr Serv 2023:appips202200008. [PMID: 36695011 DOI: 10.1176/appi.ps.202200008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
One Mind, in partnership with Meadows Mental Health Policy Institute, convened several virtual meetings of mental health researchers, clinicians, and other stakeholders in 2020 to identify first steps toward creating an initiative for early screening and linkage to care for youths (individuals in early adolescence through early adulthood, ages 10-24 years) with mental health difficulties, including serious mental illness, in the United States. This article synthesizes and builds on discussions from those meetings by outlining and recommending potential steps and considerations for the development and integration of a novel measurement-based screening process in youth-facing school and medical settings to increase early identification of mental health needs and linkage to evidence-based care. Meeting attendees agreed on an initiative incorporating a staged assessment process that includes a first-stage brief screener for several domains of psychopathology. Individuals who meet threshold criteria on the first-stage screener would then complete an interview, a second-stage in-depth screening, or both. Screening must be followed by recommendations and linkage to an appropriate level of evidence-based care based on acuity of symptoms endorsed during the staged assessment. Meeting attendees proposed steps and discussed additional considerations for creating the first nationwide initiative for screening and linkage to care, an initiative that could transform access of youths to mental health screening and care.
Collapse
Affiliation(s)
- Nicole R Karcher
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Ramona Hicks
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Jason Schiffman
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Joan R Asarnow
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Monica E Calkins
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Judith L Dauberman
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Chantel D Garrett
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Roshni L Koli
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Carlos A Larrauri
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Rachel L Loewy
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Cecilia A McGough
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - J Michael Murphy
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Tara A Niendam
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Kimberly Roaten
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Jacqueline Rodriguez
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Brandon K Staglin
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Lawrence Wissow
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Kristen A Woodberry
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Jami F Young
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Raquel E Gur
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Carrie E Bearden
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| | - Deanna M Barch
- Department of Psychiatry, School of Medicine (Karcher, Barch), and Department of Psychological and Brain Sciences (Barch), Washington University in St. Louis, St. Louis; One Mind, Rutherford, California (Hicks, Staglin); Department of Psychological Science, University of California, Irvine, Irvine (Schiffman); Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles (Asarnow, Bearden); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins, Young, Gur); Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford (Dauberman); Department of Health Services (Garrett) and Department of Psychiatry and Behavioral Sciences, School of Medicine (Wissow), University of Washington, Seattle; Department of Psychiatry, Dell Medical School, University of Texas at Austin, Austin (Koli); National Alliance on Mental Illness, Arlington, Virginia (Larrauri); Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco (Loewy); Students With Psychosis, New York City (McGough); Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Murphy); Department of Psychiatry and Behavioral Sciences, University of California, Davis, Sacramento (Niendam); Department of Psychiatry, Meadows Mental Health Policy Institute, University of Texas Southwestern Medical Center, Dallas (Roaten); Student Support and Health Services, Sacramento City Unified School District, Sacramento, California (Rodriguez); Center for Psychiatric Research, Maine Medical Center Research Institute, Scarborough, and Department of Psychiatry, Tufts School of Medicine, Boston (Woodberry); Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia (Young, Gur)
| |
Collapse
|
30
|
Choi YA, Kweon YR. Drug Attitude and Medication Adherence of Patients with Early Psychosis in South Korea: Mediating Effect of Medication Adherence Self-Efficacy. Patient Prefer Adherence 2023; 17:1247-1255. [PMID: 37201154 PMCID: PMC10187643 DOI: 10.2147/ppa.s408781] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/16/2023] [Accepted: 05/06/2023] [Indexed: 05/20/2023] Open
Abstract
Purpose This study examined the mediating effect of medication adherence self-efficacy (MASE) on the relationship between drug attitude (DA) and medication adherence (MA) in patients with early psychosis. Patients and Methods A total of 166 patients, aged 20 years or older, and who had received treatment within 5 years of their initial psychotic episode at a University Hospital outpatient center, participated in the study. Data were analyzed using descriptive statistics, t-tests, one-way analysis of variance, Pearson's correlation coefficients, and multiple linear regression. Additionally, a bootstrapping test was conducted to determine the statistical significance of the mediating effect. All study procedures adhered to Strengthening the reporting of observational studies in epidemiology (STROBE) guidelines. Results This study found a significant correlation between MA and DA (r=0.393, p<0.001), and between MA and MASE (r=0.697, p<0.001). MASE had a partial mediating effect on the association between DA and MA. The model that integrated both DA and MASE accounted for 53.4% of the variation in MA. Bootstrapping analysis indicated that MASE was a significant partial parameter (lower limit confidence interval [CI] 0.114; upper limit CI 0.356). Further, 64.5% of the study participants were either currently enrolled in college or had higher levels of education. Conclusion These findings could potentially lead to a more personalized approach to medication education and adherence, considering the unique DA and MASE of each patient. By identifying the mediating effect of MASE on the relationship between DA and MA, healthcare providers could tailor interventions to enhance the ability of patients with early psychosis to adhere to prescribed medication regimens.
Collapse
Affiliation(s)
- Yoon-A Choi
- Department of Nursing, Chonnam National University Hospital, Gwangju, South Korea
| | - Young-Ran Kweon
- Department of Nursing, Chonnam National University, Gwangju, South Korea
- Correspondence: Young-Ran Kweon, Department of Nursing, Chonnam National University, P.O. Box 61469, 60 Baekseo-ro, Dong-gu, Gwangju, South Korea, Tel +82 62 530 4966, Fax +82 62 220 4544, Email
| |
Collapse
|
31
|
Paquin V, Pries LK, Ten Have M, Bak M, Gunther N, de Graaf R, van Dorsselaer S, Lin BD, van Eijk KR, Kenis G, Richards A, O'Donovan MC, Luykx JJ, Rutten BPF, van Os J, Shah JL, Guloksuz S. Age- and sex-specific associations between risk scores for schizophrenia and self-reported health in the general population. Soc Psychiatry Psychiatr Epidemiol 2023; 58:43-52. [PMID: 35913550 PMCID: PMC9845157 DOI: 10.1007/s00127-022-02346-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/15/2022] [Accepted: 07/19/2022] [Indexed: 01/21/2023]
Abstract
PURPOSE The health correlates of polygenic risk (PRS-SCZ) and exposome (ES-SCZ) scores for schizophrenia may vary depending on age and sex. We aimed to examine age- and sex-specific associations of PRS-SCZ and ES-SCZ with self-reported health in the general population. METHODS Participants were from the population-based Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2). Mental and physical health were measured with the 36-item Short Form Survey 4 times between 2007 and 2018. The PRS-SCZ and ES-SCZ were respectively calculated from common genetic variants and exposures (cannabis use, winter birth, hearing impairment, and five childhood adversity categories). Moderation by age and sex was examined in linear mixed models. RESULTS For PRS-SCZ and ES-SCZ analyses, we included 3099 and 6264 participants, respectively (age range 18-65 years; 55.7-56.1% female). Age and sex did not interact with PRS-SCZ. Age moderated the association between ES-SCZ and mental (interaction: p = 0.02) and physical health (p = 0.0007): at age 18, + 1.00 of ES-SCZ was associated with - 0.10 of mental health and - 0.08 of physical health, whereas at age 65, it was associated with - 0.21 and - 0.23, respectively (all units in standard deviations). Sex moderated the association between ES-SCZ and physical health (p < .0001): + 1.00 of ES-SCZ was associated with - 0.19 of physical health among female and - 0.11 among male individuals. CONCLUSION There were larger associations between higher ES-SCZ and poorer health among female and older individuals. Accounting for these interactions may increase ES-SCZ precision and help uncover populational determinants of environmental influences on health.
Collapse
Affiliation(s)
- Vincent Paquin
- Prevention and Early Intervention Program for Psychosis (PEPP-Montreal), Douglas Mental Health University Institute, Montreal, QC, Canada.,Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Lotta-Katrin Pries
- Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, Maastricht University Medical Centre, Vijverdalseweg 1, SN.2.068, P.O.Box 616 6200, Maastricht, MD, The Netherlands
| | - Margreet Ten Have
- Department of Epidemiology, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands
| | - Maarten Bak
- Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, Maastricht University Medical Centre, Vijverdalseweg 1, SN.2.068, P.O.Box 616 6200, Maastricht, MD, The Netherlands.,FACT, Mondriaan Mental Health, Maastricht, The Netherlands
| | - Nicole Gunther
- Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, Maastricht University Medical Centre, Vijverdalseweg 1, SN.2.068, P.O.Box 616 6200, Maastricht, MD, The Netherlands.,School of Psychology, Open University, Heerlen, The Netherlands
| | - Ron de Graaf
- Department of Epidemiology, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands
| | - Saskia van Dorsselaer
- Department of Epidemiology, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands
| | - Bochao D Lin
- Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, Maastricht University Medical Centre, Vijverdalseweg 1, SN.2.068, P.O.Box 616 6200, Maastricht, MD, The Netherlands.,Department of Psychiatry, UMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands.,Research Institute Brainclinics, Brainclinics Foundation, Nijmegen, The Netherlands
| | - Kristel R van Eijk
- Department of Neurology, UMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands
| | - Gunter Kenis
- Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, Maastricht University Medical Centre, Vijverdalseweg 1, SN.2.068, P.O.Box 616 6200, Maastricht, MD, The Netherlands
| | - Alexander Richards
- Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, UK
| | - Michael C O'Donovan
- Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, UK
| | - Jurjen J Luykx
- Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, Maastricht University Medical Centre, Vijverdalseweg 1, SN.2.068, P.O.Box 616 6200, Maastricht, MD, The Netherlands.,Department of Psychiatry, UMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands.,Research Institute Brainclinics, Brainclinics Foundation, Nijmegen, The Netherlands.,GGNet Mental Health, Warnsveld, The Netherlands
| | - Bart P F Rutten
- Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, Maastricht University Medical Centre, Vijverdalseweg 1, SN.2.068, P.O.Box 616 6200, Maastricht, MD, The Netherlands
| | - Jim van Os
- Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, Maastricht University Medical Centre, Vijverdalseweg 1, SN.2.068, P.O.Box 616 6200, Maastricht, MD, The Netherlands.,Department of Epidemiology, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands.,Department of Psychiatry, UMC Utrecht Brain Center, University Medical Centre Utrecht, Utrecht, The Netherlands.,Research Institute Brainclinics, Brainclinics Foundation, Nijmegen, The Netherlands.,Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK
| | - Jai L Shah
- Prevention and Early Intervention Program for Psychosis (PEPP-Montreal), Douglas Mental Health University Institute, Montreal, QC, Canada.,Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Sinan Guloksuz
- Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, Maastricht University Medical Centre, Vijverdalseweg 1, SN.2.068, P.O.Box 616 6200, Maastricht, MD, The Netherlands. .,Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
| |
Collapse
|
32
|
Shah JL, Moinfar Z, Anderson KK, Gould H, Hutt-Macleod D, Jacobs P, Mitchell S, Nguyen T, Rodrigues R, Reaume-Zimmer P, Rudderham H, Rudderham S, Smyth R, Surood S, Urichuk L, Malla AK, Iyer SN, Latimer E. Return on investment from service transformation for young people experiencing mental health problems: Approach to economic evaluations in ACCESS Open Minds (Esprits ouverts), a multi-site pan-Canadian youth mental health project. Front Psychiatry 2023; 14:1030407. [PMID: 36896344 PMCID: PMC9988897 DOI: 10.3389/fpsyt.2023.1030407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/28/2022] [Accepted: 01/03/2023] [Indexed: 02/23/2023] Open
Abstract
INTRODUCTION Mental health problems are common globally, and typically have their onset in adolescence and early adulthood-making youth (aged 11-25) an optimal target for prevention and early intervention efforts. While increasing numbers of youth mental health (YMH) initiatives are now underway, thus far few have been subject to economic evaluations. Here we describe an approach to determining the return on investment of YMH service transformation via the pan-Canadian ACCESS Open Minds (AOM) project, for which a key focus is on improving access to mental health care and reducing unmet need in community settings. APPROACH As a complex intervention package, it is hoped that the AOM transformation will: (i) enable early intervention through accessible, community-based services; (ii) shift care away toward these primary/community settings and away from acute hospital and emergency services; and (iii) offset at least some of the increased costs of primary care/community-based mental health services with reductions in the volume of more resource-intensive acute, emergency, hospital or specialist services utilized. Co-designed with three diverse sites that represent different Canadian contexts, a return on investment analysis will (separately at each site) compare the costs generated by the intervention, including volumes and expenditures associated with the AOM service transformation and any contemporaneous changes in acute, emergency, hospital or service utilization (vs. historical or parallel comparators). Available data from health system partners are being mobilized to assess these hypotheses. ANTICIPATED RESULTS Across urban, semi-urban and Indigenous sites, the additional costs of the AOM transformation and its implementation in community settings are expected to be at least partially offset by a reduction in the need for acute, emergency, hospital or specialist care. DISCUSSION Complex interventions such as AOM aim to shift care "upstream": away from acute, emergency, hospital and specialist services and toward community-based programming which is more easily accessible, often more appropriate for early-stage presentations, and more resource-efficient. Carrying out economic evaluations of such interventions is challenging given the constraints of available data and health system organization. Nonetheless, such analyses can advance knowledge, strengthen stakeholder engagement, and further implementation of this public health priority.
Collapse
Affiliation(s)
- Jai L Shah
- ACCESS Open Minds, Douglas Research Centre, Montreal, QC, Canada.,Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Zeinab Moinfar
- ACCESS Open Minds, Douglas Research Centre, Montreal, QC, Canada
| | - Kelly K Anderson
- Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.,Institute of Clinical and Evaluative Sciences, Toronto, ON, Canada
| | | | | | - Philip Jacobs
- Faculty of Medicine, University of Alberta, Edmonton, AB, Canada
| | - Stephen Mitchell
- Canadian Mental Health Association Lambton Kent, Chatham-Kent, ON, Canada
| | - Thanh Nguyen
- Faculty of Medicine, University of Alberta, Edmonton, AB, Canada
| | - Rebecca Rodrigues
- Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
| | - Paula Reaume-Zimmer
- Canadian Mental Health Association Lambton Kent, Chatham-Kent, ON, Canada.,Bluewater Health, Chatham-Kent, ON, Canada
| | | | | | - Rebecca Smyth
- Canadian Mental Health Association Lambton Kent, Chatham-Kent, ON, Canada
| | | | | | - Ashok K Malla
- ACCESS Open Minds, Douglas Research Centre, Montreal, QC, Canada.,Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Srividya N Iyer
- ACCESS Open Minds, Douglas Research Centre, Montreal, QC, Canada.,Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Eric Latimer
- ACCESS Open Minds, Douglas Research Centre, Montreal, QC, Canada.,Department of Psychiatry, McGill University, Montreal, QC, Canada
| |
Collapse
|
33
|
Fusar-Poli L, Aguglia A, Albert U. Editorial: Early identification of affective and non-affective psychoses: From psychopathology to biomarkers. Front Psychiatry 2023; 14:1144943. [PMID: 36815189 PMCID: PMC9939889 DOI: 10.3389/fpsyt.2023.1144943] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/15/2023] [Accepted: 01/25/2023] [Indexed: 02/09/2023] Open
Affiliation(s)
- Laura Fusar-Poli
- Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
| | - Andrea Aguglia
- Section of Psychiatry, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.,IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - Umberto Albert
- Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.,Azienda Sanitaria Integrata Giuliano-Isontina - ASUGI, UCO Clinica Psichiatrica, Trieste, Italy
| |
Collapse
|
34
|
Fusar-Poli L, Rutten BPF, van Os J, Aguglia E, Guloksuz S. Polygenic risk scores for predicting outcomes and treatment response in psychiatry: hope or hype? Int Rev Psychiatry 2022; 34:663-675. [PMID: 36786114 DOI: 10.1080/09540261.2022.2101352] [Citation(s) in RCA: 13] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
Abstract
Over the last years, the decreased costs and enhanced accessibility to large genome-wide association studies datasets have laid the foundations for the development of polygenic risk scores (PRSs). A PRS is calculated on the weighted sum of single nucleotide polymorphisms and measures the individual genetic predisposition to develop a certain phenotype. An increasing number of studies have attempted to utilize the PRSs for risk stratification and prognostic evaluation. The present narrative review aims to discuss the potential clinical utility of PRSs in predicting outcomes and treatment response in psychiatry. After summarizing the evidence on major mental disorders, we have discussed the advantages and limitations of currently available PRSs. Although PRSs represent stable trait features with a normal distribution in the general population and can be relatively easily calculated in terms of time and costs, their real-world applicability is reduced by several limitations, such as low predictive power and lack of population diversity. Even with the rapid expansion of the psychiatric genetic knowledge base, pure genetic prediction in clinical psychiatry appears to be out of reach in the near future. Therefore, combining genomic and exposomic vulnerabilities for mental disorders with a detailed clinical characterization is needed to personalize care.
Collapse
Affiliation(s)
- Laura Fusar-Poli
- Department of Clinical and Experimental Medicine, Psychiatry Unit, University of Catania, Catania, Italy
| | - Bart P F Rutten
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands
| | - Jim van Os
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.,UMC Utrecht Brain Centre, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.,Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
| | - Eugenio Aguglia
- Department of Clinical and Experimental Medicine, Psychiatry Unit, University of Catania, Catania, Italy
| | - Sinan Guloksuz
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.,Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
| |
Collapse
|
35
|
Millman ZB, Guvenek-Cokol PE, Kim HJ, Öngür D, Carol EE. The support, treatment, and resilience (STAR) program for youth at clinical high-risk of psychosis. Schizophr Res 2022; 248:122-123. [PMID: 36037644 DOI: 10.1016/j.schres.2022.08.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Revised: 07/15/2022] [Accepted: 08/20/2022] [Indexed: 11/24/2022]
Affiliation(s)
- Zachary B Millman
- Psychotic Disorders Division, McLean Hospital, 115 Mill Street, Belmont, MA 02478, United States of America; Department of Psychiatry, Harvard Medical School, 25 Shattuck Street, Boston, MA 02114, United States of America.
| | - P Esra Guvenek-Cokol
- Psychotic Disorders Division, McLean Hospital, 115 Mill Street, Belmont, MA 02478, United States of America; Department of Psychiatry, Harvard Medical School, 25 Shattuck Street, Boston, MA 02114, United States of America
| | - Hyun Jung Kim
- Psychotic Disorders Division, McLean Hospital, 115 Mill Street, Belmont, MA 02478, United States of America; Department of Psychiatry, Harvard Medical School, 25 Shattuck Street, Boston, MA 02114, United States of America
| | - Dost Öngür
- Psychotic Disorders Division, McLean Hospital, 115 Mill Street, Belmont, MA 02478, United States of America; Department of Psychiatry, Harvard Medical School, 25 Shattuck Street, Boston, MA 02114, United States of America
| | - Emily E Carol
- Psychotic Disorders Division, McLean Hospital, 115 Mill Street, Belmont, MA 02478, United States of America; Department of Psychiatry, Harvard Medical School, 25 Shattuck Street, Boston, MA 02114, United States of America
| |
Collapse
|
36
|
Poletti M, Preti A, Raballo A. Mind the (transition) gap: Youth mental health-oriented early intervention services to overcome the child-adolescent vs. adult hiatus. Front Psychiatry 2022; 13:965467. [PMID: 36061290 PMCID: PMC9428274 DOI: 10.3389/fpsyt.2022.965467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/09/2022] [Accepted: 07/25/2022] [Indexed: 11/20/2022] Open
Affiliation(s)
- Michele Poletti
- Department of Mental Health and Pathological Addiction, Child and Adolescent Neuropsychiatry Service, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy
| | - Antonio Preti
- Department of Neuroscience, University of Turin, Turin, Italy
| | - Andrea Raballo
- Section of Psychiatry, Clinical Psychology and Rehabilitation, Department of Medicine, University of Perugia, Perugia, Italy.,Center for Translational, Phenomenological and Developmental Psychopathology (CTPDP), Perugia University Hospital, Perugia, Italy
| |
Collapse
|